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AIDS Acquired Immune Deficiency Syndrome
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HCV Viral Hepatitis C
HIV Human Immunodeficiency Virus
HTS HIV Testing Services
IDUIT Injecting Drug User Implementation Tool – also 
known as the guidance document Implementing 
Comprehensive HIV and HCV Programmes with 
People Who Inject Drugs
IEC Information, Education, Communication
INPUD International Network of People who Use Drugs
M & E Monitoring and Evaluation
MSM Men who Have Sex with Men
NGO Non-Governmental Organisation 
NSP Needle and Syringe Exchange Programme
OST Opioid Substitution Therapy
PLHIV People living with HIV
PWID People who Inject Drugs
PWUD People who Use Drugs
SRHR Sexual and Reproductive Health and Rights
STI Sexually Transmitted Infection
TB Tuberculosis
UN United Nations
UNAIDS Joint United Nations Programme on HIV/AIDS
UNDP United Nations Development Programme
UNODC United Nations Office on Drugs and Crime
WHO World Health Organization
WWID  Women who Inject Drugs
  Injecting Drug User Implementation Tool Training Manual  /  Abbreviations 4
Preface
The International Network of People who Use Drugs (INPUD) 
is a global, peer-based organisation that seeks to promote the 
health and defend the rights of people who use drugs. INPUD 
exposes and challenges stigma, discrimination, and the crim-
inalisation of people who use drugs, and their impact on the 
drug-using community’s health and rights. INPUD is a move-
ment of people who use drugs (currently and formerly) who 
support the Vancouver Declaration. The Vancouver Declara-
tion sets out the demands of people who use drugs, empha-
sising that their human rights must be respected and their 
health and well-being prioritised. INPUD is a global network 
that seeks to represent people who use drugs in interna-
tional agencies such as the United Nations and with those 
undertaking international development work. It believes that 
people who use drugs should be meaningfully represented in 
the decision-making processes that affect their lives. INPUD 
is committed to demonstrating at country level how people 
who use drugs can constructively contribute to the develop-
ment and delivery of services for our community.
www.inpud.net
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The Linkages across the Continuum of HIV Services for Key Populations 
Affected by HIV (LINKAGES) project conducts a range of HIV prevention activi-
ties to reduce HIV transmission among key populations (sex workers, men who 
have sex with men, transgender persons and people who inject drugs) and to 
improve their enrolment and retention in care. 
Introduction
Developed jointly by UNODC and INPUD, in 
collaboration with other partners, the guid-
ance document Implementing Comprehen-
sive HIV Programmes with People who Inject 
Drugs: Practical Approaches from Collabora-
tive Interventions – otherwise known as the 
Injecting Drug User Implementation Tool 
(IDUIT) – was published in 2016.  It describes 
how to implement effective programmes 
and services for HIV and HCV prevention 
interventions for and with people who inject 
drugs (PWID).
The IDUIT is based on previously published 
United Nations (UN) guidance documents, 
mainly the WHO/UNODC/UNAIDS Tech-
nical Guide for Countries to Set Targets for 
Universal Access to HIV Prevention, Treat-
ment and Care for Injecting Drug Users (rev. 
2012) and the WHO Consolidated Guidelines 
on HIV Prevention, Diagnosis, Treatment and 
Care for Key Populations (rev. 2016). 
In addition to the nine key interventions of 
the WHO/UNODC/UNAIDS Comprehensive 
Package for HIV and PWID, it includes preven-
tion and management of overdose and sexual 
and reproductive health and rights (SRHR). 
The IDUIT also covers critical enablers, strat-
egies, activities and approaches to increase 
the accessibility, acceptability, coverage, 
quality and uptake of interventions and 
services for key populations. 
It contains examples of good practice from 
around the world that may support efforts 
in planning programmes and services, 
describes issues that should be considered 
and advises on how to overcome challenges.
The IDUIT tool does not seek to ignore the 
complex policy and legislative environment 
around drugs and injecting drug use in most 
countries, nor the need for advocacy to confront 
the stigma, discrimination and human rights 
violations faced by PWID. However, it aims 
primarily to address the question: what can we 
do now, with the resources we have, in the 
kinds of environments we face, to prevent the 
spread of HIV and hepatitis C among PWID?
What is the purpose of the  
IDUIT Training Manual  
for People who Use Drugs?
The training manual is designed to support 
the roll-out of the IDUIT through capacity 
building at regional, country or local level. It 
has been developed to facilitate the work of 
trainers in organising and delivering training 
and workshops on the IDUIT to communities 
of people who use drugs to help them serve 
their own community in line with the evidence-
based and human rights-based approaches 
outlined in the IDUIT, and to interact with a 
wide range of governmental and non-govern-
mental organisations, including public health 
and drug policy makers, and harm reduction 
and HIV programme managers and staff. 
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1 Click here to read more
How to use the  
IDUIT Training Manual
The IDUIT Training Manual is complementary 
to the IDUIT on which it is based. It is there-
fore necessary for future trainers to first read 
and familiarise themselves with the original 
guidance  (the IDUIT document) before facili-
tating a workshop.
It is intended as a pick-and-choose menu of 
activities and content – from which a facili-
tator can identify and select those that best 
suit the context, audience and timeframe. 
The teaching aids and training content will 
need to be adapted to the local context. It 
is strongly recommended that at least one 
of the trainers/facilitators comes from the 
community of people who use drugs. It is 
also recommended that a person with exper-
tise on national harm reduction and drug 
policy will be present as a reference person 
during the training. Ideally this person would 
come from a national union of people who 
use drugs but, if that is not possible, a knowl-
edgeable ally of people who use drugs may 
be helpful in that role.
How is it Structured?
The trainer manual is structured in chapters 
that align broadly with the IDUIT, and includes 
content to provide basic information and facili-
tate dialogue with service providers and policy 
makers. Key chapters of the IDUIT include:
1. Community Empowerment – focusing 
on principles, definitions, and key ele-
ments of community empowerment.
2. Legal Reform, Human Rights and Stigma 
– focusing on understanding human rights 
in the context of PWUD, addressing 
human rights within programmes, examin-
ing stigma and developing programmes to 
reduce stigma and discrimination.
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2 
Legal Reform, 
Human Rights, 
Stigma and 
Discrimination
1
Community 
Empowerment
4 
Service Delivery 
Approaches
5 
Programme 
Management
Starting, managing, 
monitoring and scaling 
up a programme
Structural 
Interventions
Approaches to 
improving the 
continuum of HIV 
and HCV prevention, 
diagnosis, treatment 
and care
3 
Health and  
Support Services
Key chapters of the IDUIT
3. Health and Support Services – look-
ing at all the essential elements of harm 
reduction for HIV/HCV, including needle 
and syringe programmes, covering opioid 
substitution therapy, SRHR, hepatitis and 
overdose prevention.
4. Service Delivery Approaches – focus-
ing on the design and start-up of effective 
services, and outlining the service delivery 
models that can be implemented, such as 
community-led harm reduction services, 
peer-led outreach and drop-in centres.
5. Programme Management – discussing 
the principles of programme manage-
ment, including the benefits of effective 
management systems, understanding 
the environment, programme implemen-
tation, the practice of community-led 
monitoring and quality improvement, and 
issues around hiring and training staff.
Engaging with Policy Makers – an overview 
of the IDUIT, and ideas on how to conduct 
structured dialogue with policy/decision 
makers for further engagement and support. 
Each Module contains:
• An overview section
  Aim 
  Learning objectives 
  Expected outcomes
  List of required materials
  Overview of module components
  Reference to relevant section(s)  
in the IDUIT
• Instructions for activities
• Suggested times for activities
• Facilitators’ notes 
• Handouts.
Materials Needed for the Workshop:
• IDUIT 
• The IDUIT Brief Guide  
for People who Use Drugs
• Attendance register
• Name tags (optional)
• Flipcharts  
and marker pens
• Knowledge  
assessment sheets
• Slide projector
• Slide set
• Quizzes (these are alternative  
tools, not included as handouts)
• Workshop assessment sheet 
• Printout of presentation slides  
and/or USB drive with training  
materials (optional)
• Sterile injecting equipment, fit packs 
(including cotton, water, swabs),  
smoking equipment  
and Naloxone.
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Considerations for Training Methods
Ensure that adult learning principles are 
used during the training:
  Treat participants as independent people 
with valuable experience that should be 
extensively utilised in the training. 
  Allow participants to make their own 
decisions and to share their experiences.
  Learning should be experiential, 
participant-directed and interactive. 
• Use a variety of training methods. 
• Providing small incentives as gifts to 
recognise the participants’ effort, partici-
pation and contribution is a good way to 
encourage them.
• Consider presenting and sharing audio-
visual material that you may have access to, 
like video clips that summarise the context 
of injecting drug use in your country, as 
well as the HIV and HCV epidemic among 
PWID. Include short clips that document 
harm reduction programmes in your 
country. However, ensure that identities 
are protected and that no faces are visible. 
Considerations for Planning and 
Implementing a Policy Dialogue 
(Engaging with Policy Makers) 
The aim of including policy makers in the third 
day of the training is to highlight the critical role 
that PWUD play in implementing effective HIV 
and HCV programmes. This should be a platform 
for open discussion and sharing between policy 
makers and the community, where the voices 
of community members can be heard and their 
expertise, experience and role recognised. 
Throughout the training for community 
members, group work is designed to enable 
identification of priority areas for change. The 
facilitator should take notes of priorities iden-
tified, so that participants can choose from 
among them the ones they may want to 
discuss with policy makers.
Lessons from Previous IDUIT Training 
Suggest that Facilitators Should: 
• Aim for good coverage from the policy 
maker side. 
  Depending on the number of policy 
makers invited to speak, each should 
have 10 minutes or less to cover key 
information from their side/sector.
• Adequately support participants from 
community-led organisations to deliver 
talking points/presentations as part of the 
policy dialogue. 
  Include time on the second day of the 
training to prepare for the dialogue.
  Enable participants to:
 acknowledge positive achievements
 articulate priority changes needed
 articulate where they can 
contribute to work being done.
  Encourage  participants to demon-
strate positive and receiving attitudes 
to policy makers to allow for mean-
ingful engagement. 
Considerations for Writing a Report 
on the Workshop
Documenting the outcomes and lessons of 
completed training workshops can be useful, 
particularly if the training will be repeated. 
Useful reports include:
• A brief description of the workshop loca-
tion, dates, participants and trainers
• Tools used (e.g. agenda, handouts, assess-
ment forms etc.) in relevant language(s)
• Results of the participants’ assessments 
and feedback
• Comments and reflections
• Lessons learned and recommendations 
for future workshops.
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Proposed Workshop Agenda
Day 1  Structural Interventions
09:00 09:15 Session 1. Opening, Welcome and Administration
09:15 – 10:00 Session 2. Introduction, Expectations & Objectives
10:00 – 10:30 Session 3. The IDUIT: Background, Rationale, Structure and Guiding Principles
10:30 – 10:45 Break
10:45 – 12:30 Session 4. Community Empowerment 
12:30 – 13:30 Lunch
13:30 – 14:15 Session 4. Community Empowerment (continued)
14:15 – 15:00 Session 5. Legal Reform & Rights
15:00 – 15:15 Break
15:15 – 16:30 Session 5. Legal Reform & Rights (continued)
16:30 – 17:00 Session 6. Recap and Closing
Day 2  Structural and Health Service Interventions 
09:00 – 09:30 Session 7. Welcome & Recap 
09:30 – 10:00 Session 8. Stigma & Discrimination 
10:00 – 11:00 Session 9. Services Block 1
11:00 – 11:15 Break
11:15 – 12:15 Session 9. Services Block 2
12:15 – 13:15 Lunch
13:15 – 14:15 Session 9. Services Block 3
14:15 – 15:15 Session 9. Services Block 4
15:15 – 15:30 Break
15:30 – 16:30 Session 10. Community Involvement and Leadership in Services 
16:30 – 17:00 Session 11. Selection of Priorities for Discussion During Policy Dialogue
Day 3  Dialogue with Policy Makers 
09:00 – 09:30 Session 12. Welcome and Recap
09:30 – 11:15 Session 13. Preparing for Policy Maker Session
11:15 – 11:30 Break
11:30 – 12:00 Session 14. Assessment, Feedback and Closure
12:00 – 13:00 Lunch
13:00 – 13:20 Session 15. Welcome, Introductions & Overview of the IDUIT
13:20 – 13:50 Session 16. Overview of Local Policy Context 
13:50 – 14:20 Session 17. Overview of Existing HIV and HCV Programmes with PWID
14:20 – 14:50 Break
14:50 – 16:15 Session 18. Facilitated Dialogue: Challenges and Solutions to Enhancing HIV 
and HCV Policy and Programmes with PWID
16:15 – 16:45 Session 19. The Way Forward 
16:45 – 17:00 Session 20. Closing and Thanks
Day One
Session 1: Opening,  
Welcome and Administration 
Session:    15 minutes      Slide 1–2
Aim: To set the scene for the workshop 
and manage expectations
Steps:
• Welcome participants to the 
workshop.  
• Thank participants for their time, 
reminding them that PWUD have an 
important role in advocating and imple-
menting evidence and human rights-
based policy and practice.
• Introduce yourself and provide some 
background that is relevant to the 
training. 
• Tell people where the bathrooms are, 
where catering will be provided and 
where sterile injecting equipment and 
Naloxone can be found.
• Request that people complete an 
attendance form, including contact 
details for later networking between 
partners.
• Any other housekeeping information.
 
Session 2: Introductions, 
Expectations and Objectives
Session:    45 minutes      Slides 3–8
Aim: To understand participants’ knowl-
edge and experience and workshop 
expectations
Learning objectives:
• To facilitate networking between 
participants
• To understand participants’ 
expectations
• To inform participants about the work-
shop structure and objectives
Main points: Clarification of expecta-
tions, objectives and workshop structure
Expected outcomes:
• Establishment of new relationships 
between PWUD who are active in 
their communities
• Clarification of expectations and stated 
objectives and process to achieve these
• Baseline assessment of knowledge 
relating to HIV and hepatitis among 
PWUD
Materials Needed
Attendance register
Name tags (optional)
Materials Needed
Slide projector 
Printouts of the  
knowledge assessment 
Flipchart and 
marker pens
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Session components:
• Introductions and expectations 
(activity)
• Overview of the agenda 
• Assessment (exercise)
Synopsis:    2 minutes       Slide 3
Open the training by saying:
• In all parts of the world, PWID are 
disproportionately affected by HIV and 
the hepatitis C virus (HCV). 
• The main factors contributing to 
this situation are limited access to 
evidence-based interventions, particu-
larly needle and syringe programmes, 
opioid substitution therapy and treat-
ment for HIV and HCV infection in 
contexts where PWID are criminalised 
and stigmatised. 
• This workshop is based on global 
normative guidance on how to imple-
ment the World Health Organization, 
UNODC and UNAIDS comprehensive 
package of HIV services for PWID. 
• The IDUIT includes details of how to 
implement, and an extensive refer-
ence list for additional information. 
• Meaningful involvement of people 
who use drugs in policy making, 
programme design and implementa-
tion and in community- and individ-
ual-level knowledge and behaviour 
change is central to improving health 
outcomes for PWID.
Ground rules:    2 minutes     Slide 4
Clarify the ground rules that will guide 
the workshop. Elicit these from the 
participants. 
Introduction of icebreaker exercise:
Details:    1 minute      Slide 5
Inform participants that they will take 
part in an exercise to get to know one 
another and understand their expecta-
tions of the workshop.
Activity: Icebreaker and expectations
Duration:    20 minutes
Aim: To allow participants to get to 
know one another and understand their 
expectations of the workshop
Steps:
1. Ask participants to identify another 
person in the training that they have 
not met, or do not know very well.
2. Ask each pair to introduce themselves to 
each other, including some background on 
why they got involved with or want to get 
involved with local or national networks 
or community groups of people who use 
drugs or harm reduction services. 
3. Each person must also share their 
main expectations of the workshop. 
4. After five minutes bring people back 
together and ask them to introduce 
their partner (name and background) 
and their expectations.
5. Note the expectations on a flipchart.
6. After everyone has presented, review 
the expectations and discuss them in 
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Materials Needed
Flipchart and 
marker pens
relation to the workshop’s main objec-
tive (listed below).
7. Take note of expectations and tailor 
the workshop to cover these as far as 
possible. 
Workshop objectives:
Details:    3 minutes      Slide 6
The workshop has two parts (with the 
second focusing on policy makers), with 
interlinking objectives:
Part 1:
• To introduce people who use drugs to 
the IDUIT and Brief Guide
• To build capacity around best practices
• To build capacity to use the IDUIT 
and Brief Guide for programming and 
advocacy 
• To prepare community members for 
dialogue with service providers and 
policy makers (which will be held on 
the third day)
Part 2: 
• To raise policy/decision makers’ 
awareness of the critical role that 
the community of PWUD plays in 
the implementation of effective HIV 
programmes for PWID
Overview of the agenda
Details:    2 minutes      Slide 7
Briefly go through the three-day agenda 
with participants.
Optional activity: baseline knowledge 
assessment 
Details:    15 minutes      Slide 8
Aim: To assess participants’ knowledge 
of issues of relevance to HIV and HCV in 
the context of injecting drug use
Facilitators’ Notes
The facilitator may choose to do a 
baseline and final knowledge assess-
ment. Whether to do this or not 
should be determined in line with the 
purpose of the seminar. For seminars 
that are more focused on gathering 
knowledge and opinions of partici-
pants, the knowledge assessment 
can be skipped. If the seminar is 
aimed more at teaching participants 
about the content of the IDUIT, then 
the knowledge assessment may have 
some value in evaluating its success. 
Should the facilitator choose not to 
use the knowledge assessment, the 
content of the evaluation sessions at 
the beginning of the second and third 
days of the seminar can be noted and 
used in the evaluation report.
The same knowledge assessment 
is used at the beginning and end of 
the workshop. It is included in the 
handout section for printing, and 
is also included below to assist in 
providing instructions to participants. 
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Facilitators’ Notes
As an alternative activity, or as part 
of the above activity, request partic-
ipants to write their expectations on 
sticky notes, which can be put on the 
flipchart. They can then be read out, 
discussed and kept for review during 
the training. 
Steps:
1. Tell participants that they need to 
answer a short, anonymous knowl-
edge assessment at the beginning and 
end of the workshop.
2. Hand out copies of the assessment.
3. Tell the participants that:
– they should not consult with one 
another during this activity.
– they have 10 minutes to complete 
the assessment.
– they should include their place 
of birth and favourite food on the 
form.
– the assessment is anonymous, 
but these details help to link the 
assessments.
4. Collect the  assessments after 10 
minutes.
Session 3: The IDUIT and Brief 
Guide: Background, Rationale, 
Structure and Principles
Session:   30 minutes     Slides 9–23
Relevant section of the IDUIT: pages 
xi-xvii
Aim: To set the scene for the workshop
Learning objectives:
• To increase participants’ under-
standing of the background to, 
rationale for, and development  
of the IDUIT
• To get a common understanding of 
the principles guiding HIV and HCV 
programmes
Expected outcomes:
• Participants will understand why the 
IDUIT was developed and how it 
aligns with global policy, commitments 
and targets to end AIDS.
• Participants will have increased aware-
ness of declarations by and demands 
by PWUD to realise their human rights.
• Participants will become familiar with 
the interventions included in the WHO/
UNODC/ UNAIDS comprehensive 
package of HIV services for PWID.
Main points:
• The UNAIDS Fast Track Strategy, the 
UNGASS Outcome Document and the 
2016 Political Declaration on HIV and 
AIDS highlight the need to support 
efforts proven to reduce HIV infec-
tions among PWID, including those 
which support legal reform, reduce 
stigma and empower communities.
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Materials Needed
Printouts of the 
assessment sheets 
(in handout section of manual)
• The 2016 Political Declaration recom-
mends that 30% of services be commu-
nity-led by 2030.
• Most countries are very far from 
upholding their commitments in relation 
to the needs of PWUD.
• The IDUIT details the process on how to 
implement guidelines to meet the global 
targets.
• PWUD can use the IDUIT and Brief 
Guide to advocate for improved policy 
and practice at the national and local 
level.
Session components:
• Background and rationale 
(presentation)
• Overview of IDUIT (presentation)
• Guiding principles (interactive 
discussion)
 
Background and Rationale 
Commitments to protect the health 
and rights of PWUD
Details:     1 minute     Slide 9
Governments of countries throughout 
the world have signed a number of inter-
national agreements that express their 
commitment to protect the health and 
rights of people, including specifically 
people who use drugs.
Sustainable Development Goals
Details:     2 minutes     Slide 10
In 2015, UN member states adopted the 
2030 Agenda for Sustainable Develop-
ment. There are 17 Sustainable Devel-
opment Goals (SDGs), including goal 
3.3 – to end the AIDS epidemic by 2030 
– and others relevant to the health and 
well-being of people who use drugs. 
Click to read more
Commitments to end AIDS and 
expand community-led services 
Details:     2 minutes     Slide 11
In the United Nations Political Declaration 
on AIDS in 2016, countries reaffirmed 
their commitment to end AIDS by 2030 
(including through expansion of access 
to community-led services, with 30% of 
services to be community-led. 
UNAIDS will soon discuss (during the 
42nd meeting of its Programme Coordi-
nating Board) a recommendation that 6% 
of global funding be allocated to work on 
these issues. 
UNGASS on the World Drug Problem 
(2016)
Details:     2 minutes     Slide 12
In April 2016, countries adopted the 
UN General Assembly Special Session 
on the World Drug Problem Outcome 
Document. It calls for a health-oriented, 
gender-sensitive, human rights-based 
response to the world drug problem and 
commitments to the relevant SDGs. It 
builds on international conventions that 
do not mandate the criminalisation of 
people who use drugs. 
Click to read more
Materials Needed
Slide 
projector 
Flipchart and marker pens
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UNAIDS Fast-Track Strategy 
Details:     2 minutes     Slide 13
UNAIDS has a fast-track strategy to 
promote rapid acceleration of HIV preven-
tion and treatment services. The strategy 
specifies what percentage of people 
should have access to key prevention and 
treatment services by 2021.  
UN Guidelines 
Details:     1 minute     Slide 14
UN Guidelines based on scientific evi-
dence recommend specific interventions 
for people who use drugs so that coun-
tries can live up to their commitments. 
WHO Guidelines
Details:   2 minutes  
The WHO published guidelines on 
prevention, diagnosis, treatment and care 
for key populations which also address:
• reform of laws, policies and practices
• stigma and discrimination 
• enhanced community empowerment.
UNAIDS is expected to discuss a recom-
mendation that 6% of global AIDS 
funding be allocated to addressing social 
enablers at the 42nd meeting of its 
Programme Coordinating Board.
You can refer to these commitments and 
declaration when advocating for support 
for your work to provide community-led 
health and social services and promote 
human rights.
Comprehensive package of services 
for PWID 
Details:     2 minutes     Slide 15
WHO, UNODC and UNAIDS published 
guidelines on the comprehensive 
package of HIV prevention, treatment 
and care of PWID. The package of 
services includes:
1. Needle and syringe programmes 
(NSPs)
2. Opioid substitution therapy (OST) and 
other evidence-based drug depend-
ence treatment
3. HIV testing and counselling (HTC)
4. Antiretroviral therapy (ART)
5. Prevention and treatment of sexually 
transmitted infections (STIs)
6. Condom programmes for PWID and 
their sexual partners
7. Targeted information, education and 
communication (IEC) for PWID and 
their sexual partners
8. Prevention, vaccination, diagnosis 
and treatment for viral hepatitis
9. Prevention, diagnosis and treatment 
of tuberculosis (TB)
10. Community distribution of Naloxone.
Most UN documents refer to nine inter-
ventions. The tenth (on community 
distribution of Naloxone) comes from 
the WHO Consolidated Key Population 
Guideline (2016). 
Declarations by PWUD
Details:     1 minute     Slide 16
Community empowerment of PWUD 
is gaining momentum. Introduce the 
International Network of People Who 
Use Drugs (INPUD), established in 
Vancouver in 2006. Its manifesto and 
founding document is known as the 
Vancouver Declaration. It reclaims the 
right to self-representation and self-em-
powerment through collective action. It 
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outlines activists’ aim to replace prohi-
bition with policy informed by harm 
reduction sensibility, which respects the 
rights and dignity of people who use 
drugs. Refer participants to the handout 
on the Vancouver Declaration (2006). 
Highlight that in 2015 INPUD released 
a consensus statement developed by 
people who use drugs. The statement 
defines their human rights that need 
to be fulfilled. Additional information is 
provided on page 8 of the IDUIT.
Current state of coverage of harm 
reduction services 
Details:     2 minutes     Slide 17
In spite of the commitments govern-
ments made and the concrete recom-
mendations on how to achieve them, the 
needed policies and practices are rarely 
implemented and PWUD continue to 
suffer as a result.
• Only 10% have access to NSP. 
• Only 8% have access to OST.
• Only 14% have access to ART.
• PWUD are still criminalised.
• PWUD face stigma and discrimination.
• PWUD are often not adequately mobi-
lised to engage in policy dialogue and 
in providing services.
Overview of the IDUIT
Details:     5 minutes     Slides 18–21
Introduction 
Details:     2 minutes     Slide 18
The IDUIT was developed to help 
governments and communities work to 
improve health and protection of rights of 
people who use drugs. It is based on UN 
guidance and the values and preferences 
of people who use drugs. It addresses 
services and also ‘critical enablers’: law 
and policy reform; addressing violence; 
community empowerment. Inform partic-
ipants that this seminar is being held 
to help them use the IDUIT to promote 
better policy and practice. 
There are implementation tools for other 
communities, too (  1 min    Slide 19)
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Facilitators’ Notes
Refer participants to page 8 of the 
IDUIT for the Vancouver Declara-
tion and the INPUD website for the 
INPUD consensus statement on the 
rights of people who use drugs and 
their demands. 
Click here for read more
The facilitator should prepare a 
couple of slides on the evolution of 
the HIV epidemic nationally and its 
impact on people who use drugs, as 
well as information on access to and 
availability of interventions such as 
needle and syringe programmes and 
OST. This will help to place the work-
shop in a country context. The slides 
included provide an example of glob-
al-level information.
Tools exist that focus on sex workers 
(referred to as SWIT), men who have sex 
with men (referred to as MSMIT) and trans-
gender people (referred to as TRANSIT). 
Overview of the IDUIT structure
Details:     1 minute     Slide 20
The IDUIT provides guidance on how to 
implement HIV and HCV programmes 
with PWID. It targets health officials, 
managers of HIV and harm reduction 
programmes, civil society organisations, 
health workers and communities of PWID. 
It has five chapters; each one includes:
• descriptions of focal areas
• practical guidance
• case studies
• a comprehensive resource list.
The IDUIT Brief Guide for People who 
Use Drugs
Details:     1 minute     Slide 21
• The Brief Guide highlights the key 
points in the IDUIT. 
• It was written for people who inject 
drugs, as individuals or organising 
collectively.
• It contains checklists to help assess 
whether service provision and advo-
cacy work are carried out in line with 
evidence-informed UN recommen-
dations and known preferences of 
people who use drugs.  
• Some content in this Brief Guide is not 
addressed in the IDUIT but is informed 
by User-Activists’ Views on Best Prac-
tice in Harm Reduction, which gives 
an overview of the opinions and pref-
erences of experts and activists from 
among the community of people who 
use drugs.
Optional activity: Guiding principles for 
HIV and HCV programmes
Details:     7 minutes     Slide 22
Use the activity below to go through the 
guiding principles included in the IDUIT. 
Aim: To discuss important principles in 
HIV and HCV programmes with PWID 
Steps:
1. Ask participants to name important 
principles (i.e. values, beliefs, stand-
ards) they feel should guide HIV and 
HCV programmes for PWID. 
2. Write down the suggested principles. 
3. For each one, ask participants why 
they feel their suggested principle is 
important. 
4. At the end of the exercise compare 
the list with those included in the 
IDUIT (see below and    Slide 22).
5. Note and discuss any principles that 
were missed.
The IDUIT’s guiding principles:
• Human rights
• Community empowerment
• Community participation and  
leadership
• Acceptability of services
  Injecting Drug User Implementation Tool Training Manual  /  Day One  /  Session 3 19  Injecting Drug User Implementation Tool Training Manual  /  Day One  /  Session 3 18
Facilitators’ Notes
If time is limited, skip the exercise 
and present the guiding principles on 
  Slide 22. 
Materials Needed
Flipchart and 
marker pens
• Access to justice
• Access to quality health care
• Health literacy
• Integrated service provision
These are explained on page xxi of the 
IDUIT. The important principles of equality 
and non-discrimination run through its 
various chapters.
Conclusion: Using the IDUIT and Brief 
Guide 
Details:     1 minute     Slide 23
• They can help you learn about state-
of-the-art policy and practice to ensure 
the health and rights of PWUD. Knowl-
edge is power!
• You can check whether programmes 
for people who use drugs in your 
country or city are living up to interna-
tional standards. The checklists in the 
Brief Guide will be especially helpful 
for this.
• You can use the IDUIT and Brief Guide 
to show your government officials, 
service managers, and police the 
international standards they should be 
living up to.
Session 4:  
Community Empowerment
    150 minutes      Slides 24–37
Relevant section of the IDUIT: pages 
1-26
Relevant section of the Brief Guide: 
pages 8-9
Aims:
• To build understanding of why 
empowerment of PWUD is essential 
in HIV and HCV programming
• To facilitate the sharing of ideas 
amongst PWUD about how to stimu-
late empowerment within their own 
communities
• To help communities develop argu-
ments to convince national or local 
officials or service providers that their 
empowerment is important
Learning objectives:
To increase understanding of:
• key elements of community 
empowerment
• principles of meaningful engagement 
in drug policy, outreach and service 
provision
• establishing effective networks of 
people who use drugs
• how to use the IDUIT to advocate for 
involvement of people who use drugs
Expected outcome:
Participants will have a deeper under-
standing of how people who use drugs 
and organisations or networks of people 
who use drugs can be empowered to 
mobilise to improve the rights, health 
and well-being of PWUD. 
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Main points:
• Key elements of community 
empowerment
  Cooperation between 
communities of PWUD and other 
organisations
  Fostering outreach and service 
provision led by PWUD
  Adapting to local needs and 
contexts
  Developing organisations of 
PWUD
  Strengthening organisations and 
building capacity
  Shaping policy and creating 
enabling environments
  Sustaining the movement
• The progress of community 
empowerment should be monitored
Session components: 
• Understanding community empower-
ment (case study and discussion)
• Unpacking the elements of commu-
nity empowerment (small group 
discussions and teach-back)
Community empowerment
Details:     5 minutes     Slide 24
Community empowerment is much 
more than the involvement of people 
who use drugs in programmes. This 
module explores the different elements 
of community empowerment and how 
it affects the social, cultural, political and 
economic factors that impact on health. 
Empowerment of PWUD is essential 
to ensure that PWUD are influencing 
planning, implementation and monitoring 
of HIV and HCV programmes. By forming 
groups and networks, communities 
of PWUD can do practical things to 
strengthen their capacity for harm 
reduction and advocacy.
This session will give participants a 
chance to reflect on case studies, 
share their experiences and learn 
about the model used for community 
empowerment included in the IDUIT.  
Part 1: Understanding community
Details:  30 minutes     Slides 25–26
1. Divide participants into four small 
groups by counting from 1 to 4 and 
repeat.
2. Ask them to discuss in small groups: 
i) What is community? 
ii) What is community 
empowerment? 
iii) What are the differences between 
a community-based organisation 
and a community-led organisation?
3. After 15 minutes, ask the groups to 
present their answers and discuss. 
If needed, show    Slide 26 for points 
from the IDUIT on community-led 
organisations.
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Materials Needed
Slide 
projector 
Flipchart and marker pens
• It is crucial to note that community-led 
organisations (i.e. those led by and for 
people who inject drugs) are not the 
same as generic community-based 
organisations. 
• In community-led organisations, power 
and decision making lie in the hands of 
community members. In a national or 
international NGO, power may reside 
only with limited numbers of the 
community, or, more commonly, with 
administrators who are not community 
members.
• It is the self-determining and self-gov-
erning nature of an organisation, and 
its commitment to pursue the goals 
that its own members have agreed 
upon, that makes it a genuinely 
community-led organisation.
Activity: Case studies around 
community empowerment 
Details:  55 minutes    Slides 27–29
Aim: To use a case study of a 
community-led intervention to draw  
out and discuss key elements of 
community empowerment
Steps:
Group case discussion
Details:   20 minutes      Slide 27
1. Divide participants into groups of up 
to 10.
2. Give each group a few sheets of A4 
paper, flipchart paper and pens.
3. Allocate each group a case study. 
 The two case studies included in the 
IDUIT are:
• Organising to shape government 
policy in Indonesia (box 1.9,  
page 21)
• Community advocacy for 
improved OST in Australia (box 
1.10, page 22)
4. Invite one group member to read the 
case study out to their group.
5. Each small group should discuss 
the questions below and note their 
answers (   Slide 27):
– What does community 
empowerment mean to you?
– What top five things do you 
feel are essential to empower 
communities?
– What do you think makes this 
case study remarkable?
– What challenges do you think 
such a project would face in your 
context?
Facilitators’ Notes
Consider developing and using case 
studies from your local context to 
highlight issues around community 
empowerment.
Materials Needed
Community empowerment 
case studies included 
in the IDUIT
Flipchart, paper  
and pens for each group
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– What do you think could facilitate 
such a project to succeed in your 
context?
6. Give groups 20 minutes, then 
bring them together to share their 
answers. 
Plenary feedback and discussion on 
community empowerment 
Details:    15 minutes      Slide 28
1. Select a group to report back to the 
plenary on its definition of commu-
nity empowerment. Encourage other 
groups to share elements that were 
not included or differ from this. 
2. Share the definition below, used in 
the IDUIT. 
Community empowerment is a process 
whereby groups of people increase 
control over their lives.
It means more than involvement, partici-
pation or engagement:
• It implies community ownership, and 
action that explicitly aims at social and 
political change.
• It addresses social, cultural, political 
and economic factors that affect 
health.
• It seeks to build partnerships  
with other sectors in finding  
solutions. 
Plenary feedback and discussion on 
case studies 
Details:   20 minutes      Slide 29
1. Ask a member of one group to give 
a summary of case study 1. Ask 
that person to also share important 
elements of the case study around 
community empowerment. Encourage 
other participants who focused on this 
case study to add to this.  
2. Repeat this process for case study 2. 
3. Show the key elements of commu-
nity empowerment in the IDUIT, 
alongside   Slide 29. 
4. Compare the lists of elements devel-
oped by the groups with this figure. 
Discuss any elements that were 
missed.
5. Conclude by linking the elements 
highlighted in the case study to the 
IDUIT community empowerment 
figure (below).
Community  
Empowerment
Working  
with communities  
of people who  
inject drugs
Sustaining the 
movement
Adapting to 
local needs and 
contexts
Developing 
organisations 
of people who 
inject drugs
Strengthening 
organisations 
and building 
capacity
Shaping 
policy and 
creating 
enabling 
environments
Fostering 
outreach 
and service 
provision led 
by people 
who inject 
drugs
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Meaningful Involvement
Details:   15 minutes      Slide 30–31
Presentation on meaningful 
involvement 
Details:    5 minutes      Slides 30–31
• International guidelines recommend 
that PWID be involved in the planning, 
implementation, monitoring and evalu-
ation of programming.
• PWUD should be represented in 
decision-making bodies, such as 
committees or working groups that 
plan and evaluate drug policy and 
health policy relevant to PWUD. It 
is not enough for them just to be 
present during meetings.
• PWUD should select their own repre-
sentatives. Sometimes NGOs or 
government officials will select people 
on their own. The people they select 
may not express the views of the 
community they represent.
• PWUD should be given opportunities 
to be educated on international guid-
ance and issues in their own countries 
as their views are both experiential 
and evidence-based.
• PWUD should be given opportunities 
to have facilitated meetings to iden-
tify advocacy priorities and prepare to 
articulate them.
• People from the PWUD community 
who participate in high-level planning 
and evaluation activities should 
be accountable to the people 
they represent. They can do this 
by gathering feedback from their 
constituents and informing them on 
results of participation.
• It is important to have a national 
network/union/association of PWUD 
with funding to carry out secretariat 
functions for people representing 
PWUD in high-level meetings.
• It is helpful to have a community 
advisory board or local PWUD-led 
organisation or group to be involved 
in local-level decision making (i.e. to 
interact with harm reduction service 
providers).
• Intersectionality: when decisions are 
made about subgroups of PWUD, 
for example women who use drugs 
or MSM who use drugs, it is essen-
tial that representatives of those 
subgroups be involved.
• Involvement in providing services is 
also essential and will be discussed in 
more depth tomorrow as we discuss 
harm reduction services.
Discussion:  10 minutes
Ask participants for feedback on the 
state of meaningful involvement in the 
city/country. Ask about strengths and 
weaknesses. Take notes on flipchart.  
Organisations of people who use drugs 
Details:   45 minutes    Slides 32–37
Organisations of people who use drugs 
Details:    2 minutes     Slide 32
• Can have important roles to play at the 
local and national levels in dialogue 
about: 
 drug policy
 health and social services
  Injecting Drug User Implementation Tool Training Manual  /  Day One  /  Session 4 24
• Organisations of PWUD may exist as:
 national networks/associations/
unions 
 local formal or informal groups or 
organisations
• Important considerations for organisa-
tions of people who use drugs include:
 governance
 project management
 resource mobilisation
 developing partnerships
Governance 
Details:     3 minutes     Slide 33
• Good governance means the respon-
sible management of an organisation’s 
strategic vision and resources. It 
includes:
• Transparency (i.e. it is easy for the 
organisation’s members and partners 
to see what, how and why decisions 
are made)
• Accountability – organisation leader-
ship and/or community representa-
tives gather input from and provide 
feedback to their constituents (the 
people they represent). Emphasise 
that this relates to the organisation’s 
leadership as well as to people repre-
senting the community of people who 
use drugs on decision-making bodies 
outside the organisation, such as a 
national AIDS committee or a local 
community advisory board.
• The board (the committee that leads 
the organisation) should be made up 
of people who use drugs, and may 
include allies with the connections and 
influence that can help the organisa-
tion achieve its goals.
Project Management
Details:     1 minute     Slide 34
Organisations must:
• develop and follow realistic work plans 
and budgets that are in line with their 
vision and mission
• design projects in line with local and 
international good practices
• ensure that projects are responsive to 
the needs of their members.
Resource Mobilisation 
Details:     3 minutes     Slide 35
• Resource mobilisation is not just about 
fundraising but also involves recruiting 
volunteers, finding in-kind donations 
and developing partnerships.
• Resource mobilisation must be in 
line with the organisation’s vision and 
mission. Sometimes donors may offer 
organisations funds to do things that 
are not of high priority. Taking such 
money can take valuable staff time 
away from real priorities.
• It may be possible to raise funds 
from members of the organisation, 
i.e. through a small monthly or annual 
membership fee. This enhances a 
sense of ownership, but the sum 
should not be so high as to exclude 
people from joining. A scaled member-
ship fee may be considered.
• There may be government funding 
available for services. What capaci-
ties do community-led organisations 
need in order to apply for and manage 
these funds? What capacities does 
the organisation need to apply for and 
successfully manage these funds?
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• When funding is inadequate it is impor-
tant to partner with organisations to 
engage in budget advocacy (to advo-
cate for state funds) or to advocate to 
donors to allocate needed funds.
Developing partnerships
Details:     3 minutes     Slide 36
• Advocacy work is almost never 
done by a single organisation, but by 
coalitions.
• People who use drugs have unique 
knowledge and perspectives to 
contribute to partnerships.
• Partners can help enable members of 
groups of people who use drugs to 
join committees that oversee health 
programmes, or provide access to 
politicians and other officials.
• Partners can help guide people who 
use drugs who are unfamiliar with 
formal meeting processes, or with 
protocol for dealing with officials, 
enabling them to learn how to partici-
pate and engage effectively.
• People who use drugs should seek 
respectful and supportive allies who 
value their input and are serious about 
meaningful engagement.
Possible partners include: 
Details:     3 minutes     Slide 37
• NGOs that provide harm reduction 
services
• other community-led and communi-
ty-based organisations and NGOs
• community-led networks and organisa-
tions of sex workers, men who have 
sex with men, transgender people, 
young key populations, and people 
living with HIV
• local women’s organisations, faith-
based organisations and other 
community groups or relevant organi-
sations with a focus on gender-based 
violence, human rights, access to 
health, access to justice, adult educa-
tion and skills building, and a range of 
other social issues and entitlements
• governmental organisations, such 
as policy makers, law enforcement, 
health and social services social 
programmes.
Discussion:   30 minutes
Facilitate a group discussion based on 
the following question: 
• What are the strengths and weak-
nesses of national and local organisa-
tions of people who use drugs?  
Prompt participants to address govern-
ance, project management, resource 
mobilisation and partnerships.  
Make note of the highest-priority 
strengths and weaknesses.
Alternatively, the discussion could be 
guided by the chart of Monitoring Indi-
cators for Empowerment of People who 
Use Drugs, Table 1.2, page 25 of the 
IDUIT.                                                                                     
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Session 5: Legal Reform and 
Human Rights 
    90 minutes      Slides 38–44
Relevant section of the IDUIT:  
pages 29–48
Relevant section of the Brief Guide: 
pages 10–12
Aim: To provide practical advice on how 
to address human rights issues faced 
by PWUD, by exploring approaches for 
legal and policy reform, including ways 
to monitor interventions to promote and 
protect human rights
Learning objectives:
To gain an understanding of:
• advancing human rights 
• documenting human rights violations
• addressing stigma and discrimination
• developing local programming to 
reduce stigma and discrimination
Expected outcomes:
• Increased awareness of protection of 
the rights of PWUD
• Familiarity with different approaches 
to advance the rights of PWUD
Main points:
• Reviewing and reforming laws and 
policies
  Removing criminal sanctions 
for drug use and possession for 
personal consumption
• Advancing human rights
  Access to justice
  Documenting human rights 
violations
• The progress of legal reform, 
enhancing rights and efforts to 
address stigma and discrimination 
should be monitored 
Session components:
• Introduction to human rights 
(brainstorm)
• Overview of UN protections of human 
rights, and human rights declarations 
by PWUD (presentation)
• Legal reform (case study discussion)
• Advancing human rights (activity)
Introduction
Details:     2 minutes     Slide 38
Tell participants that this session will 
start by exploring their understanding of 
human rights and reflecting on interna-
tional conventions around human rights, 
along with documents and statements 
introduced earlier concerning the rights 
of people who use drugs.
Activity: Human rights brainstorm 
Details:  10 minutes     Slide 39
Aim: To emphasise that all people 
have human rights and that these are 
protected by global and local laws
Materials Needed
Flipchart and 
marker pens
Materials Needed
Slide 
projector 
Flipchart and marker pens
Steps:
1. Ask people in the larger group to 
give examples of human rights. Note 
these down on the flipchart.
2. Ask people why they think rights are 
important.
3. Ask the group to explain why rights 
apply to PWUD.
4. Ask participants to give examples of 
human rights violations experienced 
by themselves or by someone they 
know.
5. Based on the answers, encourage 
the group to come up with a simple 
understanding of human rights.
Reviewing and reforming policy 
Details:   15 minutes    Slides 40–41
After the brainstorming activity, empha-
sise how rights violations commonly 
affect PWUD, particularly in contexts 
where drug use is criminalised. The inter-
action between rights violations and the 
risk of infectious diseases is well docu-
mented, and this combination drives the 
HIV and HCV epidemics among PWUD.
Reflect on the introduction section, 
noting that the international conventions 
around drug use contain flexibilities that 
allow a country to refrain from crim-
inalising the possession of drugs for 
personal consumption. 
Explain that laws criminalising the use 
or possession of drugs or of injecting 
equipment:
• can deter PWUD from seeking 
services due to fear of arrest and 
prosecution
• can impede the effectiveness of HIV 
and HCV responses.
Tell participants that harm reduction refers 
to policies, programmes and practices 
that primarily aim to reduce the adverse 
health, social and economic conse-
quences of the use of licit and illicit drugs.
Explain that while drug possession is crim-
inalised in most countries, several have 
changed their laws to protect the rights 
and improve the health and well-being of 
citizens. Direct participants to the IDUIT, 
where a legal framework for law reform is 
provided along with several examples of 
how law reform has taken place. 
Present the case study of Portugal (slide 
41, page 36 in the IDUIT) to document 
the improved health benefits from law 
reform. Explain how since 2001 Portugal 
has used administrative charges for 
people who use drugs, which includes 
referral to health, social, legal and other 
services. Portugal’s rate of drug use 
is lower than the European average 
and HIV and HCV infection rates have 
decreased. Even though drug policy 
reform can go further to protect the 
rights of PWUD, remind participants that 
they can still use the example of Portugal 
in their advocacy work.
Facilitators’ Notes
Encourage participants to share their 
knowledge of law reform in their 
country or region. If recent develop-
ments have taken place, structure 
discussions around these, noting 
positive health outcomes in other 
countries, including Portugal.
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Advancing human rights 
Details:     6 minutes     Slide 42
Explain that there are many ways to 
advance the rights of PWUD. The IDUIT 
provides descriptions, examples and 
case studies of how to do this (pages 
37-49), specifically relating to:
• increasing access to justice
• documenting human rights violations 
• addressing violence and other barriers 
from law enforcement officers
• ending forced or compulsory 
treatment
• increased access to health services in 
detention
• advocating for gender-responsive 
harm reduction services. 
While it is not possible to cover all of 
these aspects in the training, activities 
focusing on two of these areas will take 
place:
1. Increasing access to justice and legal 
literacy (placeholder on    Slide 43, 
instructions below)
2. Documenting human rights violations 
(placeholder on    Slide 44, instruc-
tions below)
Activity: Advancing human rights 
Details:   17 minutes    Slides 43
Aim: To provide participants with five 
case studies illustrating the effective-
ness of legal literacy and legal aid in 
addressing human rights.
Steps:
1. Briefly introduce the session, show 
one case study slide (  Slide 43) 
and talk very briefly about the other 
four (see IDUIT pages 38-40). Refer 
to summaries below. Each case 
study shows different approaches 
that can be successful:
i. Indonesia: Around 120 people 
who use drugs have been trained 
across eight provinces in Indonesia 
to provide paralegal assistance to 
their peers whose drug-related 
cases are before the courts.
ii. Ukraine: Organisations in Ukraine 
provide legal services through 
contracting individual lawyers or 
law firms. An additional benefit has 
been attracting new clients who 
come for the legal services and 
stay for the HIV prevention ones.
Facilitators’ Notes
Adapt the activities for the local 
context, and use local examples 
where appropriate. You may also wish 
to adapt their number, depending on 
the size of the group.
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Materials Needed
Slide projector 
Flipchart, paper  
and pens for each group
Case examples included  
in the IDUIT (see below)
iii. Eastern Europe and Central Asia 
(EECA): Hand-help.ru is an online 
resource that provides easily 
understandable explanations of 
laws and regulations on drug 
use in the Russian Federation. A 
Regional HIV Legal Network was 
established in 2012, with support 
from UNDP and co-financing from 
the European Union. The network 
operates in nine countries in 
EECA and has a system to submit 
complaints online.
iv. Tanzania: Members of the Tanza-
nian Network of People who Use 
Drugs (TANPUD) and others in harm 
reduction programmes carry Know 
Your Rights cards to use in case of 
arrest. It has very often been found 
that the police are less likely to 
harass people who use drugs who 
have the card with them.
 The card is made up of three  
basic sections:
a. Rights of the beneficiary (a 
person who uses drugs or who 
works with people who use 
drugs)
b. Responsibilities of the police
c. Responsibilities of the 
beneficiary.
 The card can be used by people 
who are arrested to show that 
they know their rights and that the 
police also have legal responsibil-
ities. It can be found in the IDUIT 
on page 40.
2. Give the groups 10 minutes to review 
the case study and answer the ques-
tions below:
a. What lessons can be learned?
b. How could these be applied in your 
context?
3. Ask the groups to share their 
responses to the larger group for a 
brief discussion.
Activity: Documenting human rights 
violations 
Details:   40 minutes     Slide 44
Aim: To enable participants to under-
stand how to record and document inci-
dents of human rights violations
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Facilitators’ Notes
Hand out and use cards from your 
context (if they exist) highlighting the 
rights and protections of PWUD in 
your country. Consider using this as 
the basis for the activity and discus-
sion rather than the case studies and 
cards from other countries.
Materials Needed
Flipchart, paper  
and pens for each group
The ‘6W’ guide for  
documenting human  
rights violations  
(IDUIT, page 43, box 2.9) 
Steps:
1. Introduce the purpose of the group 
work.
2. Split participants into three groups.
3. Explain the task: to develop a short 
case study of human rights violations 
based on a real event they are aware 
of or have experienced themselves.
4. Have participants write this up on a 
flipchart (15 minutes).
Have each group report back to the 
plenary and assess their case study 
against the 6W Guide from the IDUIT. 
Stimulate a discussion around this (8 
minutes for presentation, critique and 
discussion per case study). Emphasise 
that answering each of the 6W questions 
(what, where, when, who, why, how) 
is essential to effectively record and 
document incidences of human rights 
violations.
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Facilitators’ Notes
Using the 6W Guide from the IDUIT 
(page 42), go through each case 
study from the group work, and 
check that all the 6W questions have 
been addressed. Facilitate discussion 
with participants and encourage them 
to identify what is missing. Further 
information for you to cover during 
discussions is found on pages 40-42 
of the IDUIT.
What
What violation occurred? What was 
the accusation made, the law cited or 
the weapon used?
Where
The street, building or facility, and the 
address
When
The time, day, date and year of the 
incident
Who
Who was the direct victim? Who were 
the perpetrators? Are there witnesses 
or other people with direct knowledge 
of the violation (e.g. medical staff, 
police, outreach workers)?
Why
Gather assessments or documenta-
tion from those most closely involved 
as to the circumstances, motivations, 
actions or words that led up to the 
violation.
How
How did the violation occur, and how 
did the victim’s status as a person 
who uses drugs contribute to the 
violation?
Adapted from United Nations Devel-
opment Programme, 2014, Know Your 
Rights, Use Your Laws: Handbook for 
legal empowerment of people who live 
with or are at risk of HIV, their close 
ones, and service providers, UNDP, 
New York) and Kaplan, K., 2009, Human 
Rights Documentation and Advocacy: 
A field guide for organizations of people 
who use drugs, Open Society Institute, 
New York.
Session 6: Recap and Closure
Activity: Reflections on the day
Details:  30 minutes     Slide 45
Aim: To wrap up the day and summarise 
key points around the topics covered
Learning objective:
Participants will learn what their main 
advocacy priorities are
Main point: 
Having a limited number of specific advo-
cacy priorities will help PWUD achieve 
their advocacy goals
Expected outcome:
Advocacy priorities will be identified for 
further use during the policy dialogue on 
the third day of the seminar or for use in 
subsequent advocacy work.
Session components: 
• Group work
• Reporting back from group work and 
recording priorities for later use
Steps:
1.  Break the participants into three 
groups. Each group will discuss one 
of the following topics:
• Legal reform
• Human rights 
• Community empowerment.
2. Give the groups 20 minutes to 
decide, based on the day’s discus-
sion, which two key priorities they 
would like to highlight as areas where 
change is needed during the dialogue 
with policy makers on Day 3.
3. Give each group three minutes to 
report back on the priorities they 
chose.
4. In preparing for the policy dialogue, 
the facilitator should take note of the 
priorities they chose for use, and add 
them to slide 109.  
Materials Needed
Flipchart and pens
Sheet of blank paper  
(A4) for each participant
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Day Two 
Session 7: Welcome, Recap  
and Planning
Session:  30 minutes     Slides 46–48
Aim: To review key lessons from Day 1 
and to have a preview of plans for Day 2
Learning objectives:
• Participants will be reminded of key 
points covered on Day 1
• Participants will identify learning priori-
ties for the day
Expected outcome:
Guidance on the priorities that should be 
covered as part of the second day 
Main point:
Overview of local HIV and HCV services 
and learning priorities
Session components:
• Recap (exercise)
• Refinement of agenda (discussion)
Introduction 
Details:    5 minutes      Slide 46
Welcome people to the second day of 
the workshop. Complete relevant regis-
tration forms. Use the activity below 
to reflect on important things people 
learned on the previous day.
Activity: Top 5 
Details:   15 minutes    Slides 47
Aim: To highlight learning from the 
previous day
Steps:
• Ask participants to think about yester-
day’s training. Remind them of the 
areas covered.
• Give them 5-10 minutes to write down 
the five most important things they 
learned yesterday.
• Encourage them to share items on 
their lists, without repeating points.
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Materials Needed
Slide projector 
Flipchart and 
marker pens
 
Sheets of plain paper  
(one per participant) 
Materials Needed
Plain sheet of paper
Plan for the Day 
Details:   10 minutes     Slide 48
After the activity, inform participants that 
today’s sessions will cover stigma (a 
continuation of discussion from IDUIT, 
Chapter 2); health and support services 
(Chapter 3); service delivery approaches 
(Chapter 4) and programme management 
(Chapter 5).
The IDUIT provides information on how 
to implement these activities with or by 
communities of PWUD. It also includes 
comprehensive resource lists of more 
detailed guidance on specific elements. 
The Brief Guide provides checklists you 
can use to check whether programmes 
in your country or locality are living up to 
international standards.
Inform participants that they will learn 
about stigma and international standards 
for health and support services. Note 
that, throughout the day, their country’s 
achievements will be highlighted along-
side the priority changes needed and the 
community’s capacity to contribute to 
making those changes. The community 
may want to raise and discuss these 
points during the meeting with policy 
makers/service providers on the third day. 
 
Session 8: Stigma and 
Discrimination 
Session:  30 minutes    Slides 49–55
Relevant section of the IDUIT:  
pages 49-55
Relevant section of the Brief Guide: 
pages 13-14
Aim: To increase understanding of how 
stigma and discrimination affect PWUD 
and outline strategies to address these 
issues
Learning objectives:
• Participants will gain an understanding 
of types of stigma
• Participants will develop greater 
insight into local-level programmatic 
interventions to address stigma and 
discrimination
• Participants will learn about strategies 
to reduce stigma and discrimination in 
the broader community
Expected outcomes:
• Increased awareness and under-
standing of the ways that stigma and 
discrimination affect PWUD
• Increased knowledge of interventions 
to reduce stigma towards PWUD
Main points:
• Involvement of PWUD in local-level 
programming can be effective in 
reducing stigma and discrimination. 
• Attitudes towards PWUD can be 
changed through engaging with the 
media and stakeholders and providing 
PWUD with a voice. 
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Session components:
• Anonymous survey (exercise)
• Introduction to stigma and discrimina-
tion (brainstorm)
• Stigma and discrimination activity 
Introduction 
Details:    5 minutes      Slide 49
People who use drugs regularly experi-
ence structural violence in the form of 
stigma and discrimination. The language, 
policies and practices of legal, health and 
educational institutions and the media 
often create, reinforce and perpetuate 
this stigma. 
This makes it more difficult to reform 
drug laws or properly resource HIV and 
HCV prevention, diagnosis, treatment 
and care programmes for people who 
use drugs. Stigma can lead to toleration 
of human rights violations against people 
who use drugs and is also used to legiti-
mise discriminatory practices.
Explain that this session will explore 
different dimensions of stigma and cover 
some practical actions that participants 
can advocate for or get involved in to 
reduce stigma and discrimination. 
Understanding stigma and 
discrimination 
Details:    5 minutes      Slides 50–51
Ask participants to develop a definition 
of stigma and discrimination. Add to it as 
needed (   Slide 50). 
Compare in relation to the UNAIDS termi-
nology guidelines (2015) (   Slide 51).
Note that UN guidance (UNAIDS, WHO, 
UNODC) emphasises the importance 
of addressing stigma in HIV program-
ming. Reduction of stigma is considered 
a ‘social enabler’ or ‘critical enabler’ 
together with protection of human rights 
and legislative reform (as mentioned on 
Day 1).
What does stigma look like? 
Details:   15 minutes    Slide 52
Aim: To explore different forms/expres-
sions of stigma
Steps:
1. Introduce the session and explain the 
aim. 
2. Discuss each of the types of stigma, 
asking the audience for specific 
examples under each heading. 
a Stigma from individuals – e.g. 
people locking up their valuables 
when visited by a person who 
uses drugs 
b Institutional stigma – e.g. treat-
ment guidelines that exclude 
people who use drugs
c Self-stigma (internalised) – e.g. 
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Materials Needed
Slide projector 
Flipchart and 
marker pens
 
Handout of  
anonymous survey
people who use drugs feeling that 
they are bad people
d Stigma by association – e.g.  stig-
matisation of people who work 
with people who use drugs.
Activity: Brainstorm and discussion 
on local-level programming to reduce 
stigma and discrimination 
Details:  20 minutes     Slides 53–55
Aim: To learn about ways to engage with 
local programming to reduce stigma and 
discrimination.
Steps:
1. Ask participants to give examples of 
how stigma and discrimination can 
be addressed.
2. Refer back to the classification of 
stigma used in the earlier exercise 
(self-stigma, stigma from others, 
institutional stigma and stigma by 
association).
3. Facilitate discussion among partici-
pants to develop concrete examples 
of interventions that could be used 
to reduce stigma and discrimina-
tion. Note these interventions and 
approaches on the flipchart.
4. Encourage participants to think about 
any interventions listed in the IDUIT 
that have not yet been suggested, 
including those listed in the back-
ground information section below 
(use    Slide 54 to support the 
discussion). 
5. Summarise key points of the session 
(   Slide 55).
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Facilitators’ Notes
Write up the types of stigma under 
separate headings on flipchart paper, 
and ask participants to add exam-
ples under each heading. This can be 
done on rotation – as individuals or 
groups. Affix the pieces of flipchart 
paper onto the wall if it makes the 
exercise easier. Following the activity 
encourage participants to explain the 
examples of stigma they have chosen 
and why they have been placed under 
their respective headings. Refer to 
page 50 of the IDUIT for additional 
information and examples.
Materials Needed
Flipchart and 
marker pens
 Session 9: Health and Social 
Services
     240 minutes      Slides 56–93
Relevant section of the IDUIT: pages 
57–94
Relevant section of the Brief Guide: 
pages 15–27
Aims: 
• To learn about internationally recom-
mended standards for HIV and HCV 
services for PWUD
• To evaluate local and/or national 
services from the point of view of 
people who use drugs
• To identify priority topics for discus-
sion with policy makers/service 
providers or for further advocacy or 
actions by people who use drugs
Learning objectives:
• Participants will learn about key 
recommendations concerning:
1. NSPs
2. OST
3. SRHR
4. Services for WWID
5. HTS and ART
6. Hepatitis services
7. Overdose 
8. Drug checking (addressed in the 
Brief Guide not the IDUIT)
• Participants will form opinions on 
priority areas for advocacy and action 
by people who use drugs
Expected outcomes:
• Increased awareness of IDUIT- and 
PWUD-recommended approaches to 
key services
• Identified priorities for further action
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Facilitators’ Notes
It is not possible to cover everything 
in the IDUIT. Encourage partici-
pants to review the case studies and 
resources provided in the IDUIT to 
address stigma within organisations 
(page 51) and in the broader commu-
nity (pages 52–54). 
People who use drugs engage in 
processes to identify their problems, 
analyse causes, identify priorities 
and develop solutions. International 
guidance, including the IDUIT, recom-
mends that services engage in this 
way with people who use drugs 
because such methods strengthen 
programme relevance, build life and 
relationship skills and help ensure the 
long-term success of programmes. 
People who use drugs can refer to 
the IDUIT and the Brief Guide when 
advocating for their involvement in 
reducing stigma.
Programmes should monitor and 
evaluate efforts to address stigma, 
discrimination and violence. Poten-
tial indicators and options to do this 
are provided on pages 54–55 of the 
IDUIT.
Main points:
• NSPs (definition, commodities, 
good-practice principles, peer outreach 
workers)
• OST (definition, common medications, 
process, good-practice principles)
• Hepatitis (epidemiology, definition, 
prevention, diagnosis, work-up and 
treatment)
• HTS and ART (definition, counselling, 
different testing modalities, adherence 
support)
• SRHR (contraception, perinatal 
services, condoms and lubrication, 
sexual assault)
• Overdose (prevention, management, 
community-led Naloxone distribution)
Approach:  
Presentation and group work. In each 
of the four hour-long blocks, present 
key points from the IDUIT on two types 
of services, followed by group work. 
In group work, participants will discuss 
how services in their countries live up 
to IDUIT recommendations, and identify 
priorities for change. It is recommended 
to build the four blocks as follows:
1. OST & NSPs
2. HTS and ART & hepatitis services 
3. SRHR & WWID
4. Overdose & drug checking
Session components:
Presentations and group work
Introduction
Details:    5 minutes      Slide 56–57
Aims: 
• To learn about international recom-
mendations on quality services for 
people who use drugs
• To identify achievements in the 
country in relation to international/
IDUIT recommendations
• To identify priority changes needed 
to live up to international/IDUIT 
recommendations
• To identify how the PWUD community 
can contribute to improving quality of 
and access to needed services
Approach: 
1. Presentation of an overview of inter-
national standards from the IDUIT
2. Group discussion of how this 
country/city measures up and iden-
tification of priority achievements, 
changes needed, and actions that 
can be taken
3. Discussion at the beginning of the 
third day of priorities to be addressed 
with policy makers/service providers
Key services to be addressed include:
• NSPs
• OST
• SRHR
• Services for WWID
• HTS and ART
• Hepatitis services
• Overdose 
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Materials Needed
Slide projector 
Flipchart and 
marker pens
• Drug checking (inform participants that 
drug checking is not covered in the 
IDUIT but is included here because it 
was a priority identified by people who 
inject drugs, and is addressed in the 
Brief Guide)
Explain that you will work through the 
services in four blocks, each covering 
two of the services. First there will be a 
PowerPoint presentation on content from 
the IDUIT and Brief Guide highlighting 
the key internationally recommended 
practices.
Block 1: Needle and Syringe Programmes 
(NSPs) and Opioid Substitution Therapy
Details:  55 minutes    Slides 58–67
Relevant section of the IDUIT:  
pages 62–71
Needle and syringe programmes
Open the discussion around NSPs using 
the placeholder slide (  Slide 58).
Overview 
Details:     3 minutes     Slide 59
• NSPs are programmes that primarily 
distribute sterile injecting equipment. 
• The provision of sterile injecting equip-
ment through NSPs is highly effective 
in reducing transmission of HIV and 
hepatitis B and C.
• NSPs should also have systems 
in place for returning, collection 
and destruction of used injecting 
equipment.
• Strict exchange (requiring people to 
return used needles and syringes) is 
not advised. 
• Strict exchange is a barrier to effective 
HIV response. 
• Equipment should be provided regard-
less of returns.
• A system should be provided to 
increase returns and collection of used 
equipment in the community.  
• NSPs increase access to other health 
and social services.
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Facilitators’ Notes
• Depending on whether the partici-
pants intend to work at the national 
level or local level, the facilitator 
can guide them to hold discussions 
in relation to the relevant approach 
to services.
• Be flexible and adapt the day’s 
activities based on the group’s 
priorities and learning needs. 
Services that are not relevant to 
the country can be removed from 
the presentation and discussion.
• Using one flipchart sheet for each 
service discussed, take careful 
notes on the key priorities iden-
tified by participants, for use at 
the end of the day when they will 
select which ones to discuss with 
policy makers.
NSP commodities
Details:     3 minutes     Slide 60
• Sterile needles and syringes (ideally 
low-dead-space syringes) 
• Condoms and lubricant
• Filters
• Sterile water
• Alcohol and cotton swabs
• Spoons
• Puncture-proof containers
• Acidifiers
• Tourniquets
Ideally, NSPs also: 
• distribute IEC materials
• provide referrals to quality and rele-
vant health and social services
• have Naloxone available for overdose 
treatment.
Modes of NSP service delivery 
Details:     3 minutes     Slide 61
Drop-in centres – taking care of the 
whole person 
Details:     2 minutes     Slide 62
• Food
• Laundry facilities
• Showers/baths
• Comfortable seating area
• Sleeping space
• Computer/internet facilities
• Creche facilities
Best-practice characteristics of NSPs 
Details:     3 minutes     Slide 63
• low-threshold, easy to access
• offer a range of free commodities
• engage community members in 
the selection and distribution of 
commodities
• do not impose the strict exchange of 
needles and syringes
• do not restrict the number of needles 
and syringes provided and do not 
prevent secondary distribution
• offer a range of other support and care 
services
• have a safe disposal plan to prevent 
accidental hazards 
• offer overdose prevention and 
management services
• use opportunities to discuss risk 
reduction with people who inject 
drugs
• integrated with and refer to other 
services 
• continually assess results to under-
stand the changing needs of their 
clients.
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Fixed services Mobile services
Drop-in centre – 
a safe place for 
PWUD to spend 
time and access 
services
Mobile clinics – 
services provided 
through an auto-
mobile that visits 
different areas
NSP programme 
centre – initial 
model for service 
provision
Outreach/back-
pack – outreach 
workers travel the 
streets providing 
services and 
commodities
Pharmacies, 
vending machines, 
drug treatment 
sites, etc
Secondary syringe 
distribution – 
people who inject 
drugs distribute 
needles and 
syringes 
Opioid Substitution Therapy 
Overview:    3 minutes     Slide 64
OST is an effective, safe and cost-effec-
tive medical treatment. It is proven to:
1. reduce frequency of injecting heroin 
or other opioids
2. reduce the risk of overdose
3. reduce the risk of transmission of 
bloodborne viruses such as HIV and 
hepatitis C
4. reduce criminal activity
5. be effective in encouraging adher-
ence to ART for people living with 
HIV, and adherence to TB treatment.
OST good practices 
Details:     8 minutes     Slides 65–66
• OST should be free of charge or 
affordable.
• OST should be offered in a 
welcoming, non-stigmatising and 
confidential environment.
• OST should be offered in a conven-
ient location and at convenient times 
(enabling clients to work and go about 
their daily affairs).  
• OST services should provide adequate 
doses to eliminate need for additional 
opioids in order to avoid feeling ill 
(adjusting doses as needed when 
other medical treatment, such as some 
antiretroviral medicines, requires it). 
• Use of illegal drugs by OST clients 
should be handled in a non-punitive 
manner.
• People should be able to access the 
service long-term and should be offered 
a voluntary option to taper doses. 
• Tapering doses should never be done 
without careful thought and discussion 
with service providers of additional 
support that may be needed.
• A range of OST medicines such as 
methadone, buprenorphine and diacet-
ylmorphine (medical heroin) should be 
offered for clients to choose from.
• Once people are stable, take-home 
doses should be offered as well as 
documentation needed by clients who 
travel.
• Social integration support should be 
available on a voluntary basis.
• Services should work with family and 
friends to create a supportive envi-
ronment for clients (while maintaining 
confidentiality).
• Services should address the special 
needs of pregnant women (including 
informing them about the risks 
involved with opting to stop OST treat-
ment or illegal opioid use while preg-
nant, and consideration of the need to 
increase dosage with weight gain).
• Services should provide Naloxone and 
training in its administration.
• OST should be available for pregnant 
women who are opioid-dependent.
• OST should be available in prison.
• OST programmes should offer clients 
means of providing feedback on how 
to improve services and to advocate 
for change when necessary.
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Group work on NSP and OST 
Group work:  20 minutes
Reporting back:   10 minutes
  Slide 67
After the presentations on NSPs and 
OST, ask the participants to break 
into two or four small groups. If there 
are OST programme clients present, 
have half the groups discuss OST and 
encourage these clients to join those 
groups; if there are none present, elimi-
nate group work on this topic and ask all 
groups to discuss NSPs. Give the groups 
20 minutes to discuss whether local/
national services adhere to IDUIT-recom-
mended practices. They should prepare 
to present back for 5 minutes on:
• the 3 main things that are going well
• the 3 main things that need to change
• how PWUD might get involved in 
promoting change. 
Block 2: Testing and Treatment
Details:    60 minutes     Slide 68–75
Relevant sections of the IDUIT: pages 
72–76; 84–86
Open the discussion around testing  
and treatment using the placeholder:   
  Slide 68
Overview:    2 minutes     Slide 69
• HIV and HCV testing services are an 
entry point to HIV and HCV prevention 
and treatment services and are essen-
tial to care and life-sustaining treat-
ment for people living with HIV.
• Testing and counselling services can 
help link people to harm reduction 
services to prevent HIV transmission, 
and access treatment for HIV and 
hepatitis.
Voluntary testing and counselling 
good practices
Details:    8 minutes     Slides 70–71
• Testing for HIV, HCV or TB should be 
done in line with the WHO’s ‘5 Cs’ 
principles:
• consent 
• confidentiality 
• counselling
• correct test results 
• connected to follow-up services.
• Testing for HIV and HCV should be avail-
able outside of medical settings with the 
assistance of trained outreach workers. 
• When rapid tests for HIV and HCV are 
used, clients should be assisted to 
access confirmation testing in medical 
settings in the case of positive results.
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Materials Needed
Handouts on good  
practices for OST and NSP
Flipchart and 
marker pens
• All testing should be free of charge.
• Repeat testing for HIV and HCV  
(i.e. once every 6 months) should  
be offered.
• Self-testing for HIV should be made 
possible (whereby people are given 
test kits with instructions for private 
use). 
• Staff of harm reduction services 
should be aware of the symptoms 
of TB and able to make referrals to 
testing and treatment services. 
• TB screening should be available for 
people who use drugs living in coun-
tries where TB prevalence is high.
HIV and HCV treatment
Details:    2 minutes      Slide 72
• Globally, people who inject drugs tend 
to have tragically low access to treat-
ment for HIV, TB and hepatitis, despite 
strong evidence that treatment is as 
effective for people who use drugs as 
it is for other populations.  
• People who inject drugs have lower 
rates of access to treatment. This is 
often due to:
  stigma and discrimination
  services not being adapted to their 
needs 
  excessively high drug pricing by 
pharmaceutical companies and 
limited will of governments to 
demand lower prices.
Good practices for treatment for 
people who inject drugs
Details:     8 minutes     Slides 73–74
• Regulatory barriers excluding PWUD 
from access to treatment should be 
removed.
• Harm reduction services should 
help link people to care or offer CD4 
testing and/or clinical check-ups in 
low-threshold settings (preferably 
with drug user-friendly physicians and 
clinics when possible).
• Adherence support, including peer 
support, should be offered for PWUD.
• OST should be available for people 
dependent on opioids who choose to 
enrol to support their treatment adher-
ence. The WHO recommends that 
antiretroviral medicines be provided at 
OST sites.
• Specific fears and concerns of people 
who use drugs should be addressed in 
treatment literacy programing.
• PWUD with experience of treatment 
for the diseases should be engaged 
to provide peer support for treatment 
adherence and navigating access to 
medical and social services.
• People who drop out of treatment 
should be given special attention to 
address their reasons.
• Measures should be in place to ensure 
continuity of treatment for people 
coming into and out of prison.
• Services for HIV, hepatitis, TB and 
OST should be adequately integrated 
to ensure convenience for patients.
• PWUD should be engaged in efforts 
to reduce pharmaceutical pricing and 
increase access to medicines.
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Group work on testing and treatment 
Group work:  20 minutes
Reporting back:  20 minutes
  Slide 75
After the presentation, ask the partic-
ipants to break into two or four small 
groups. If there are any open-status 
PLHIV or people living with HCV present, 
encourage them to lead discussions 
on treatment in half of the groups. 
No one should be pressured to reveal 
their status, but rather they should be 
welcomed to do so if they want to. If 
there are no open-status participants 
present, have all groups discuss testing. 
Suggest that they discuss whether local/
national services adhere to good prac-
tices and IDUIT-recommended practices. 
They should prepare to present back for 
5 – 10 minutes on:
• the 3 main things that are going well
• the 3 main things that need to change
• how PWUD might get involved in 
promoting change. 
 
Block 3: Sexual and Reproductive Health 
and Rights (SRHR) and Addressing the 
Needs of Women who Use Drugs
Details:   60 minutes     Slide 76–85
Relevant sections of the IDUIT: pages 
48, 76–81
Open the discussion using the place-
holder slide:   Slide 76
Sexual and reproductive health and 
rights (SRHR) 
Overview:   2 minutes      Slide 77
People who use drugs have sexual lives 
and have the right to choose whether 
they want to start a family or not. This is 
why SRHR are important. People who use 
drugs are people first and foremost, and 
have the same needs as non-drug users.
SRHR considerations for PWUD
Details:   3 minutes      Slide 78
• Condoms and lubricants and other 
safer sex supplies should be offered 
free of charge.
• Education about sexual and reproduc-
tive health should be offered as well 
as means of birth control. 
• Harm reduction services should address 
the specific needs and preferences of 
women, men who have sex with men, 
transgender people and sex workers. 
• Clinics that diagnose and treat STIs, 
provide family planning counselling 
and services, and provide prenatal 
care should be knowledgeable about 
and take into consideration the special 
needs of people who use drugs. Harm 
reduction services should refer their 
clients to clinics that they know are 
‘friendly’ to people who use drugs. 
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Materials Needed
Handouts on good  
practices in testing  
and treatment
Flipchart  
and pens
STI Services
Details:   2 minutes      Slide 79
• STI services should meet basic stand-
ards of quality and quantity. 
• Components of an STI service 
package:
 Screening and treatment for 
common STIs (e.g. syphilis, chla-
mydia, gonorrhea)
 Provision of information
 Enhancing or ensuring partner noti-
fication and management
 Assessment of perception of risk 
and counselling on safer sex
 Arrangement of follow-ups
 Provision of confidential HTS. 
Addressing the needs of women  
who use drugs
Details:    Slide 80
1. Unique needs of women 
Details:   3 minutes      Slide 81
Attention to the needs of women who 
inject drugs is necessary because of:
• overall higher HIV and HCV prevalence
• gender-based violence
• gender norms (as a barrier)
• ‘second on the needle’
• sex work overlaps
• increased stigma and discrimination
• criminalisation of drug use in 
pregnancy
• child custody
• SRHR violations 
• lack of services
2. Addressing the needs of women 
Details:   10 minutes     Slides 82–83
• Harm reduction services should make 
safe spaces available to women
• Harm reduction services should 
employ women who inject drugs and 
support community mobilisation of 
women who use drugs
• Sexual and reproductive health 
services should provide non-judge-
mental education about the effects of 
drugs on menstruation, pregnancy and 
breastfeeding. They should address 
the dangers of opioid withdrawal 
during pregnancy 
• Prenatal services and post-natal 
services, including childcare, should 
be provided
• Women who use opioids should be 
supported to access opioid substitu-
tion therapy
• The myth that drug use equals child 
abuse should be opposed
• Possession of condoms should never 
be used by law enforcement as 
evidence of engagement in sex work
• Sterilisation or abortion should never 
be coerced or forced
• Survivors of sexual assault should be 
linked to community-based responses 
to violence.
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3. Mobilisation and empowerment 
Details:   10 minutes     Slide 84
Develop collectives of women who use 
drugs
• Spaces to meet 
• Discreet advertising 
• Organisational support
• Resources for peer education
• Up-to-date information on relevant 
research
• Engage with the group 
• Support sustainability:
  Stakeholder linkages 
  Funding and training opportunities 
At minimum, employ women who inject 
drugs as volunteers, staff, and/or as 
managers.
Group work on SRHR and addressing 
the needs of women 
Group work:  20 minutes
Reporting back:  10 minutes
  Slide 85
After the presentations on SRHR and 
addressing the needs of women who 
inject drugs, ask the participants to break 
into two or four small groups. Half of 
the groups should discuss SRHR and 
the other half should discuss addressing 
the needs of women. Suggest that they 
discuss whether local/national services 
adhere to IDUIT-recommended practices. 
They should prepare to present back for 
5 minutes on:
• the 3 main things that are going well
• the 3 main things that need to change
• how WWUD might get involved in 
promoting change. 
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Materials Needed
Handouts on good  
practices for SRHR  
and addressing the  
needs of women
Flipchart and 
marker pens
Block 4: Overdose Prevention and 
Management and Drug-Checking 
Programmes
Details:   60 minutes     Slide 86–93
Relevant sections of the IDUIT: pages 
91–93 (overdose programming)
Relevant section of the Brief Guide: 
pages 19–20, 21–22 (drug checking)
Overdose Programming 
Open the discussion around overdose 
programming using the placeholder:  
  Slide 86
Details:   1 minute      Slide 87
• Overdose is the leading cause of 
drug-related deaths and is preventable. 
• Overdose prevention and manage-
ment programmes include the distri-
bution of Naloxone to people who 
inject/use opioids, and to people who 
live and work with them, to save lives 
and empower communities. 
Key components of overdose 
programming
Details:   9 minutes     Slide 88–89
• Harm reduction programmes should 
offer training on overdose, including 
resuscitation and administration of 
Naloxone to people who use opioids 
and their friends and families. 
• Detoxification/rehabilitation 
programmes, and providers of 
services to people who use drugs, 
should offer training to their staff on 
overdose and have Naloxone available. 
They should also distribute Naloxone 
to people who use drugs and their 
friends and families post-release 
(including prisoners and people 
exiting detoxification/rehabilitation 
programmes).
• Legal or regulatory barriers to 
providing or administering Naloxone 
outside of medical facilities should be 
removed.
• Trainings and educational materials 
should address how to recognise an 
opioid overdose and how to perform 
resuscitation on someone overdosing 
on drugs when Naloxone is not avail-
able or suitable to help.
• Local myths about overdose should be 
addressed in trainings and educational 
materials.
• Naloxone should be available in 
pharmacies.
• First responders (fire, ambulance, 
police) should be equipped with 
Naloxone.
• Law enforcement should be prevented 
from accompanying emergency 
services responding to overdose.
• Means to check the quality and purity 
of drugs should be available to people 
who use drugs. For example, strips 
designed to identify fentanyl in urine 
may help people identify fentanyl in 
drugs. Though the evidence base 
for using fentanyl strips this way is 
limited, it should be explored urgently.  
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Programming to make drug checking 
available
Open the discussion around drug checking 
using the placeholder:   Slide 90
Introduction to drug-checking 
programming
Details:   2 minutes     Slide 91
Prohibition leads to unregulated produc-
tion of drugs, which can lead to incon-
sistent quality and purity. This can lead 
to major health harms including death. 
Programmes enabling people who use 
drugs to test their drugs can help them 
make safer informed choices about what 
they consume. Drug-checking program-
ming is not addressed in the IDUIT, but 
is discussed in the Brief Guide.
Drug-checking programming 
Details:   8 minutes     Slide 92
• There should be ongoing action to 
advocate the legalisation of drugs. (As 
one informant quoted in User-Activ-
ists’ Views highlighted: “If drugs were 
legal, we wouldn’t need to test them 
… all the information you’d need … 
it’d be right there on the label.”)
• Drug-checking kits on a full spectrum 
of drugs, including opioids, should 
be available through harm reduction 
services or special sites.
• Festival operators and club owners 
should provide drug-checking services.
• There should be mechanisms in place 
to respond to outbreaks of tainted/
adulterated drugs.
• Harm reduction staff should be able to 
handle drugs for checking without fear 
of legal prosecution.
• Further research on drug-checking 
programmes should be promoted.
Group work on overdose program-
ming and drug-checking programming 
Group work:  20 minutes
Reporting back:  20 minutes
  Slide 93
After the presentations on overdose 
programming and drug-checking 
programming, ask the participants to 
break into two or four small groups. 
Half of the groups should discuss over-
dose and the other half should discuss 
addressing drug-checking programming. 
Suggest that they discuss whether 
local/national services adhere to recom-
mended practices. They should prepare 
to present back for 5 minutes on:
• the 3 main things that are going well 
• the 3 main things that need to change 
• how PWID might get involved in 
promoting change. 
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Materials Needed
Handouts on good  
practices for overdose  
programming and  
drug-checking programming
Flipchart  
and pens
Session 10: PWID Community 
Leadership in Services 
Session:  60 mins    Slides 94–101
Relevant section of the IDUIT: pages 
100–124
Relevant section of Brief Guide: pages 
23–27 
Aim: To help participants explore ways 
they can get involved in harm reduction 
programming
Learning objectives:
Participants to gain an understanding of:
• ways they can help improve the 
quality of harm reduction services
• arguments to use in advocating for 
services to hire PWID
• the potential to start and manage a 
harm reduction service themselves.
Expected outcomes:
• Participants will be motivated to get 
involved
• Participants will know about resources 
that can be used to advocate for 
greater meaningful involvement and 
for support of community mobilisation
Main points:
• Fundamentals of community-led harm 
reduction services
• PWID can help improve quality of 
services
• PWID should be employed by services
• PWID should be given opportunities to 
run their own services
Session components:
• Presentation
• Group work
Open the discussion around PWID 
community leadership in services using 
the placeholder:   Slide 94
Presentation:   20 minutes
Fundamentals of community-led harm 
reduction services 
Details:    4 minutes      Slide 95
Some fundamentals for community-led 
harm reduction services that help ensure 
that services meet the needs of people 
who use drugs:
• The organisation should have a values 
statement supportive of people who 
use drugs, developed with their close 
participation.
• People who inject drugs should hold 
decision-making positions in the 
management structure. 
• The safety and human rights of staff 
and clients who use drugs must be 
protected. 
• The organisational strategy should be 
responsive to changing needs in the 
community. 
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Materials Needed
Slide projector 
Flipchart  
and pens
• An independent body composed 
of community members (e.g. drug 
user unions) should be set up to deal 
with concerns of the community and 
engage in treatment advocacy. 
• The lived experience of people who 
use drugs and the services that 
have a positive impact on their lives 
should be documented to ensure that 
learning can be built upon and shared.
• The confidentiality of programme 
clients and staff must be protected.
Community-led quality improvement 
Details:    4 minutes      Slide 96–97
• International standards recognise 
that programmes must engage with 
people who use drugs in order to 
maintain and improve the quality of 
services. 
• Services for people who use drugs 
must be ‘real’ and responsive to the 
context, environment and needs of 
clients. PWID have unique knowledge 
that should be taken into account. 
• Community-led feedback from PWID 
is the most accurate way of evaluating 
and improving the quality of services. 
• Improving the quality, accessibility and 
acceptability of programme services 
requires routinely collecting feedback 
on the community’s experience of 
services. 
• The community’s experiences of 
services can be collected through:
 community committees. (High-
light that PWID can organise such 
committees to meet regularly and 
communicate with the manage-
ment of services to provide feed-
back and new ideas. Refer to the 
handouts for a sample community 
committee report) 
 special meetings and engagement 
with community representatives
 feedback sheets
 surveys
 informal discussions with commu-
nity members who access services. 
Arguments to encourage employment 
of PWID as outreach workers
Details:   6 minutes     Slides 98–99
Employing people who use drugs is 
recommended as a good practice for 
harm reduction services, and getting a 
job with a harm reduction service is a 
good way for people who use drugs to 
get involved in improving the health and 
protecting the rights of their community. 
A comprehensive resource on employing 
people who use drugs is Harm Reduction 
at Work. (The IDUIT is dedicated to the 
loving memory of one of its co-authors, 
Raffi Balian.) 
Click here to see whole document
Harm Reduction at Work outlines the top 
8 reasons for services to hire people who 
use drugs:
1. Employing drug users demonstrates 
a programme’s commitment to 
improving the health and human 
rights of people who use drugs. 
2. Employees who use drugs can 
become excellent role models for 
other drug users. 
3. People who use drugs are often the 
most effective public health messen-
gers for reaching other people who 
use drugs. 
  Injecting Drug User Implementation Tool Training Manual  /  Day Two  /  Session 10 50
4. Hiring people who use drugs 
provides employers with direct 
access to valuable knowledge about 
the needs and practices of their 
target populations.
5. Being gainfully employed in jobs that 
are valued and recognised as socially 
important contributes directly to 
improved self-esteem. 
6. Working in a structured environment 
allows people who use drugs to gain 
important skills that can facilitate 
future entrance into other jobs. 
7. Working in community-based 
projects is integral to increased feel-
ings of belonging and contributing to 
a community. 
8. Employing and organising people 
who use drugs contributes to civic 
engagement and political responsi-
bility for drug users and the organisa-
tion itself. 
PWID can run their own services
Details:   6 minutes     Slide 100
People who use drugs can run their own 
services. A good example of a PWID-run 
programme is the one managed by the 
San Francisco Drug Users’ Union. See 
handout: Case Example: A communi-
ty-led drop-in centre in the USA.
The San Francisco Drug Users’ 
Union runs a drop-in centre offering 
low-threshold services for drug users, 
provided by drug users. The centre 
operates in the Tenderloin District, the 
lowest-income neighbourhood in the city 
and the one with the highest concentra-
tion of people who inject drugs.
The drop-in centre offers services 
including needle distribution (in conjunc-
tion with the state department of public 
health), Naloxone for overdose, rapid 
testing for HIV and HCV, wound care, 
and education. It also provides bathroom 
access and internet access, both impor-
tant amenities for people who inject 
drugs, many of whom live on the streets. 
It is the largest fixed-site NSP in San Fran-
cisco, serving over 350 people each week 
and exchanging an average of 30,000 
syringes monthly. Volunteers and staff are 
all people who use drugs. Some do street 
outreach, and a volunteer crew cleans 
up discarded injection equipment in the 
neighbourhood. This service has helped 
build and maintain support for the centre 
in the wider local community. The drop-in 
centre is a base for activism too, such as 
organising marches for drug users’ rights. 
Because the community in San Francisco 
is quite transient, there is some turnover 
of staff and volunteers, but this has not 
affected the centre’s ability to provide 
consistent services. The centre is funded 
by the state, nonprofit donors and private 
donations. It is currently open five days a 
week but is seeking funding to open on 
additional days.
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Group work:  20 minutes
Reporting back:  20 minutes
  Slide 101
Break the participants into three groups. 
Ask them to discuss and report back (5 
minutes each) on the questions below.
Group 1: Community-led quality 
improvement
• How do national/local programmes 
measure up to the recommendations?
• What three things need to change?
• How can PWID promote better 
involvement in improving programme 
quality?
Group 2: PWID as staff of programmes
• How do national/local programmes 
measure up to the recommendations?
• How can PWID promote better 
involvement in improving programme 
quality?
Group 3: PWID-run services
• Are there any programmes like the 
San Francisco Drug Users’ Union?
• How could the community advocate 
for support of a similar programme?
Session 11: Selection of Priorities 
for Discussion During Policy 
Dialogue
Session:  30 minutes
Aims: 
• Reflections on the day
• Selection of priorities for discussion 
with policy makers or for further work 
by the community of people who use 
drugs
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Materials needed
8 flipcharts with priorities  
recorded from the day’s  
exercises related to services 
A white/black board or flipchart with 
the visual image below drawn on it
Im
por
ta
nc
e
Achievability
Steps:  
1. Explain to the participants that for 
the next day’s dialogue with policy 
makers, they will have to select a 
limited number of priorities to raise in 
the discussion. This exercise will help 
them identify priorities.
2. Break the participants into groups 
and assign each group one of the 
services that was discussed today. 
Give them the flipchart paper with 
the three priorities listed for that 
service (as noted by the facilitator 
during presentations from group 
work earlier in the day). 
3. Give each group three post-it notes 
and ask them to write a priority on 
each one.
4. Explain to the participants that they 
will be asked to place the post-it note 
on the board in a spot that reflects 
both how achievable the change is 
and how important it is. The higher 
a post-it note is placed, the more 
important it is, and the further to the 
right it is placed, the more achievable 
it is. In discussing achievability, the 
facilitator should guide participants to 
think about how feasible it is for that 
change to take place within three to 
five years given the situation in their 
country.
5. Give each group five minutes to 
discuss placement of their post-it 
notes.
6. Ask each group to place their post-it 
notes on the board and give a brief 
explanation for the placement. Allow 
some time for discussion if there 
are differing opinions among other 
participants.
7. Once all of the priorities have been 
placed on the board, focus discussion 
on the priorities that were placed in 
the top right quadrant, signifying the 
most important and most achievable. 
In plenary discussions the facili-
tator can guide the participants to 
consensus on the top three to four 
priorities they may want to raise in 
discussions with policy makers.
8. Once the top three to four priorities 
have been selected, the facilitator 
should add them to the PPT slide for 
use during the preparation session 
for the policy dialogue during the 
next day (   Slide 109).
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Day Three
Session 12: Welcome, Recap and 
Planning
Session:  30 mins     Slides 102–103
Aim: To review the plan for the day
Session components:
• Recap (exercise)
• Refinement of agenda (discussion)
Introduction
Details:   5 minutes     Slide 102
Welcome people to the third day of the 
workshop. Complete relevant registration 
forms. 
Activity – Top 5:   15 minutes
Aim: To highlight and reflect on learning 
from the previous day.
Steps:
• Ask participants to think about yester-
day’s training. 
• Remind them of the areas covered.
• Give them 5-10 minutes to write down 
the five most important things they 
learned yesterday.
• Encourage them to share items 
on their lists, without repeating 
information.
Plan for the day 
Details:   10 minutes     Slide 103 
After the activity, inform participants 
that today’s sessions will help them 
prepare for their dialogue with decision 
makers. Remind them that selections 
will be made, for discussion with deci-
sion makers, of priority positive achieve-
ments, priority changes needed, and key 
actions that the PWID community can 
take to contribute to positive change.
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Materials Needed
Slide projector 
Materials Needed
Plain sheet of paper
Session 13: Preparing For a 
Dialogue With Policy Makers
Session:   105 mins   Slides 104–109
Aim: To prepare for a dialogue with 
policy makers around policy and program-
ming for PWUD. 
Learning objectives:
• To develop talking points/presenta-
tions about existing HIV and related 
services for PWID, focusing on:
  successes
  unmet needs and challenges
  potential areas for support and 
partnerships with policy makers
• To prepare participants to respond 
to and engage with policy makers 
strategically
Expected outcome:
Participants to be prepared to maximise 
the opportunity to engage with policy 
makers.
Main points:
• Effective key messages
• Effective engagement strategies and 
behaviours
Session components:
• Activity – developing talking points and 
presentation
• Discussion – tips for successful 
engagement 
Introduction
Details:   5 minutes     Slides 104
Preparation for the dialogue session aims 
to ensure a smooth and effective dialogue. 
This session includes an activity for partic-
ipants to develop their talking points/pres-
entation, and discussion around positive 
engagement with policy makers. 
It is important to start the session by 
indicating that the main objective of 
the dialogue with policy makers is to 
highlight the importance of the role that 
PWID play in an effective response.
Give participants background to the dia-
logue, outline the objectives and expected 
outcomes and let them know what infor-
mation was provided to policy makers. 
Go through the agenda and the list of 
invited and confirmed participants. Where 
possible, provide information to assist 
participants to plan for the meeting.
  Injecting Drug User Implementation Tool Training Manual  /  Day Three  /  Session 13 55  Injecting Drug User Implementation Tool Training Manual  /  Day Three  /  Session 12 54
Materials Needed
Slide projector 
Flipchart and 
marker pens
Handout
Facilitators’ Notes
The facilitator needs to have advance 
knowledge of the workshop agenda 
and materials sent to the policy makers, 
and be familiar with the invited and 
confirmed participants, along with, if 
possible, some background to their 
work and potential areas of alignment. 
This information should be shared with 
participants to enable them to prepare 
for the dialogue session.
Effective preparation 
Details:   15 mins    Slides 105–106
Focus on your audience’s needs. State 
the benefit of participating in the event 
– in invitations, agendas and in the 
introductory welcome on the day. Also 
explain why the event and your work are 
important for them. 
Prepare for the engagement and for the 
participants. Understand their priorities, 
interests, background and any particular 
policies or programmes that would align 
with their mandate. 
A meeting should be a dialogue. Give 
stakeholders the chance to react, raise 
their concerns and provide their perspec-
tives. A workshop format (rather than 
presentations) is better for interaction.
1. Developing the content of your 
presentation
  Focus on your key message and 
whatever background information 
your audience needs.
2. What is your key message? 
  Pick no more than three priorities, 
plus back-ups.
  If you are at the planning stage of 
a project, present some idea of 
where your work will lead.
3. Why is this important for policy? 
  Sum this up in a few sentences – 
for yourself and for others. 
  Discuss facts/data and stories/
anecdotes for each priority.
  Identify potential state- or 
district-specific, real-life implica-
tions of policies that are currently 
being discussed.
  Think through clearly and carefully 
why your message is important. 
4. What are you asking the policy 
maker?
  Make sure you know what exactly 
you want them to do
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Tips
• Write down the questions you 
want to ask the policy maker. 
• Brainstorm responses to questions 
you may get. 
• Discuss ways to follow up after the 
meeting.
• Establish a rapport/communicate 
regularly. 
• Be friendly and adopt a positive 
attitude towards policy makers.
• Find out what they want.
• Present solid evidence and get it 
right (be prepared).
• Be careful about what you say (the 
person next to you may be in your 
next meeting).
• Speak clearly and concisely – avoid 
jargon.
• Avoid arguing.
• Present factual, non-emotive 
responses if you disagree on a 
point (avoid negative, aggres-
sive reactions – whether in the 
form of body language or verbal 
responses). 
• Make your comments personal and 
provide local context. 
• Give material to the policy maker 
(e.g. one-page organisational 
overview, business card, contact 
details). 
• Offer to be a resource.
• Be sure to thank everyone. 
Common Challenges and Questions:
What if the policy maker  
misunderstands me? 
Policy makers meet people every day 
and do not always feel passionately 
about all topics. They may not know or 
understand the core issues affecting 
PWID. It is important to identify ways in 
which your issues and priorities might 
complement theirs. Ask how your organ-
isation could support the policy maker’s 
priorities. If interest still seems limited, 
shorten the conversation and move on.
What if the policy maker disagrees with 
my organisation’s objectives  
or request?
First, remember that relationships are 
the most important part of engagement. 
Listen and try to understand the policy 
maker’s perspective. Be prepared to 
respond without attacking. Hard questions 
are usually not personal and do not neces-
sarily reflect disregard for your issue. 
Handle these by being prepared, calm, 
polite, and happy to answer questions.
What do I do if I don’t know the answer 
to a question?
Never make up an answer. It’s okay not 
to know something. Acknowledge that 
you do not know the answer and that 
you will find out, and then follow up.
Adapted from: 
National Coordinating Centre for Public Engagement, 
Guide to Working with Policy Makers, available at 
https://www.publicengagement.ac.uk/plan-it/who-en-
gage-with/policy-makers (accessed 18 September 
2017); UNAIDS, ACT 2015! Advocacy strategy toolkit, 
available at http://www.unaids.org/sites/default/files/
media_asset/advocacy_toolkit_en_0.pdf (accessed 
18 September 2017); National Association for the 
Education of Young Children, Mastering Meetings 
with Policymakers, available at http://www.naeyc.org/
content/mastering-meetings-policymakers (accessed 
18 September 2017).
Activity – planning for the policy 
dialogue 
   80 minutes      Slides 107–109, 
with    Slide 109 updated to include 
priorities from previous work
Aim: To prepare for the dialogue with 
policy makers
Learning objective: 
Participants will learn what issues might 
be raised to best discuss their priorities
Expected outcome:
Participants will have ‘talking points’ 
related to the priorities they have chosen 
(which can be used in the policy dialogue 
or in future advocacy work)
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• Take pictures outside of the office 
or during the meeting with the 
elected official, if allowed. Share 
and use appropriately.
• If a policy maker requests informa-
tion, respond within a week.
• Cultivate the relationship:
  Be a source of information and 
a voice for the issues affecting 
PWID. Provide information, 
updates, and feedback regu-
larly to the policy maker’s office 
to strengthen your position. 
  Take advantage of all engage-
ment opportunities, including 
emails, in-person meetings, 
site visits etc.
Session components:
• Group work
• Presentation and discussion of group 
work
Introduction
Use this activity to build on the talking 
points. Explain that the way in which infor-
mation is provided, and how responses 
from policy makers are received, can 
influence the outcome of engagement. 
There is value in spending time to prepare 
to engage positively and use the policy 
engagement to its full potential. 
Steps:
1. Ask participants to join one of the 
following four groups, in accordance 
with their knowledge and interest:
a. Legal reform
b. Human rights
c. Services
d. Community empowerment
 Make adjustments if some groups 
have too few people.
2. Show slide 109, updated with the 
priorities identified on Days 1 and 2.
3. Each group should develop talking 
points for a five-minute presenta-
tion and assign someone to lead it, 
covering their top priority issue and 
related message. Each message 
should include:
• why it is important for the organi-
sation (include statistics, numbers 
and a story connecting the priori-
ties, the policy maker’s priorities/
personal history, and the request)
• why it is important for policy 
makers.
 If time permits, they may prepare for 
a second priority issue.
4. Give each group 30 minutes to 
prepare their presentations and five 
minutes to present them.
5. After each presentation, allow for 
a five-minute discussion with all 
present about how it might be 
improved.
Conclusion:   5 minutes
Close the session by revising ways to 
improve the dialogue. Encourage groups 
to work on their presentations and to 
practise the talking points. 
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Materials Needed
Flipchart and pens  
for each group
Session 14: Assessment,Feedback 
and Closure
Session:  20 minutes    Slide 110
Options
If the seminar was more aimed at 
teaching participants about the IDUIT 
than at gathering information and opin-
ions from them about potential changes, 
then the facilitator may decide to use a 
pre- and post-test learning questionnaire. 
Otherwise, feedback should be gathered 
from participants on the most valued 
learning points. 
Option 1: Pre- and post-seminar tests
 20 minutes
Aim: To assess participants’ knowledge 
of the issues of relevance to HIV and 
HCV in the context of injecting drug 
use and to get their feedback on the 
workshop
Expected outcome:
Information on improvements in knowl-
edge by participants as a result of the 
training will be available for use.
Steps:
1. Hand out copies of the assessment 
and evaluation sheets.
2. Tell the participants that:
• They should not consult with one 
another during this activity.
• They have 20 minutes to complete 
the assessment and feedback 
sheet.
• They should include their place 
of birth and favourite food on the 
assessment form.
• The assessment is anonymous, 
but having these details helps link 
the assessments.
3. Give participants 20 minutes to 
complete the assessment and 
feedback.
4. Collect completed forms. 
End the session by letting participants 
know that they are well prepared for 
the policy dialogue that will start after 
lunch. Remind them of the importance of 
starting the session on time.   
Option 2: Feedback on most valued 
learning points 
 20 minutes
Activity – Top 5
Aim and learning objectives: 
To identify the learning points from 
the seminar that were most valued by 
participants
Expected outcome:
Feedback that can be used for reporting 
on the seminar and for planning further 
activities 
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Materials Needed
Printouts of the  
assessment sheets 
Printouts of the  
participant feedback sheets
Steps:
1. Request participants to think about 
the whole training. 
2. Remind them of the areas covered.
3. Give them five to ten minutes to 
write down the five most important 
things they learned.
4. Encourage them to share the items 
on their lists, without repeating 
information.
 
Session 15: Welcome, 
Introductions and Overview  
of the IDUIT
Session:  20 mins    Slides 111–126
Aim: To set the scene for the policy 
dialogue and manage expectations 
Learning objective: To increase partic-
ipants’ understanding of the value of 
engaging the community in the HIV 
response from their perspective
Expected outcome: An understanding 
of why the IDUIT was developed and its 
potential role to improve HIV and HCV 
programmes and policy for PWID   
Main points: Overview of objective, 
background (including global policy 
context) and rationale
Session components:
• Presentation
Materials Needed
Slide projector 
Sheets of plain paper  
(one per participant)
Materials Needed
Attendance register 
Name tags (optional)
Projector and  
slide set
Facilitators’ Notes
Slides outlining the local HIV epidemic 
among PWID should be included in 
the introduction section.
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Welcome and administration 
Details:  4 minutes     Slide 111–113
• Welcome participants to the policy 
dialogue (   Slide 111).
• Introduce yourself and provide rele-
vant background. 
• Tell people where the bathrooms are 
and where catering will be provided.
• Request that people complete an 
attendance form.
• Ask each person to introduce 
themselves. 
• Go through the objectives of the 
dialogue (   Slide 112):
  To highlight global and national 
commitment to preventing and 
treating HIV and HCV among 
PWID
  To introduce policy makers, service 
providers and others to the IDUIT
  To provide an opportunity to share 
knowledge and engage around 
increased support for and provi-
sion of recommended HIV and 
HCV services with PWID
  To provide a networking 
opportunity  
  To highlight the critical role that 
PWID play in the implementation 
of effective HIV programmes 
aimed at them. 
• Briefly go through the agenda  
(   Slide 113).
Background and rationale 
Details:  5 minutes    Slides 114–119
1. In September 2015, UN member 
states adopted the 2030 Agenda for 
Sustainable Development. Goal 3.3 is 
to end the AIDS epidemic by 2030  
(   Slide 114). 
2. The UNAIDS Fast-Track strategy is 
aligned with the SDGs and empha-
sises a five-year window (2016-2021) 
for rapid acceleration of HIV treatment 
and prevention services, to end AIDS 
by 2030. The strategy articulates 
the ‘90–90–90’ treatment target and 
a prevention target of reducing the 
annual number of new HIV infections 
to 500,000. Things need to be done 
differently, with investments and 
implementation of evidence-based 
interventions to meet these targets  
(   Slide 115).
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Policy Dialogue Meeting
13:00–13:20 Welcome, introductions 
and overview of the 
IDUIT
13:20–13:50 Overview of local policy 
context
13:50–14:20 Overview of existing 
HIV and HCV pro-
grammes with PWID
14:20–14:50 Break
14:50 16:15 Facilitated dialogue: 
challenges and solu-
tions to enhancing HIV 
and HCV policy and 
programmes with PWID
16:15–16:45 The way forward
16:45 17:00 Closing and thanks
3. In the UN General Assembly Special 
Session on the World Drug Problem 
outcome document in April 2016, 
member states confirmed support  
(  Slide 116): 
 We reiterate our commitment  
to end by 2030 the epidemics  
of  AIDS and tuberculosis, as  
well as combat viral hepatitis,  
other communicable diseases, 
inter alia, among people who 
use drugs, including people 
who inject drugs
4. The outcome document has opera-
tional recommendations organised 
around five chapters. Three of these 
are most relevant for HIV and PWID  
(  Slide 117).
 Chapter 1: Treatment of drug use 
disorders, rehabilitation, recovery 
and social reintegration; prevention, 
treatment and care of HIV/AIDS, viral 
hepatitis and other bloodborne infec-
tious diseases
 Chapter 2: Ensuring the availability of 
and access to controlled substances 
exclusively for medical and scientific 
purposes, while preventing their 
diversion
 Chapter 3: Cross-cutting issues: 
drugs and human rights, youth, chil-
dren, women and communities 
 Click here to see full document
5. Global targets to reduce number of 
new HIV infections amongst people 
who inject drugs by 2015 were not 
achieved. Instead HIV infections 
amongst people who inject drugs 
rose by 33% between 2009 – 2015  
(  Slide 118). 
 Sustainable Development Goal (SDG) 
Target 3.3. and the UNGASS 2016 
Outcome Document commit to 
reducing HIV amongst people who 
inject drugs by 75% in 2020 and to 
90% by 2030. 
6. 2016 High Level Political Declaration 
on Ending AIDS (  Slide 119):
• Adopted in June 2016, the 2016 
Political Declaration expresses 
states’ commitment to review 
and reform laws that reinforce 
stigma and discrimination. For the 
first time in a political declaration 
on HIV and AIDS, there is a list of 
laws to be reviewed. 
• The Political Declaration commits 
to building people-centred systems 
for health by strengthening health 
and social systems, including for 
populations that epidemiological 
evidence shows are at higher risk 
of infection, and by expanding 
community-led service delivery to 
cover at least 30% of all service 
delivery by 2030. 
 Click here to see full document
Comprehensive package of services 
for people who inject drugs
Details:    3 minutes      Slide 120
Ending AIDS and HCV epidemics is 
possible, but increased access to 
evidence-based interventions is required. 
To prevent and manage HIV infections 
it is essential that the comprehensive 
package of HIV prevention, treatment 
and care of PWID, as recommended by 
WHO, UNODC and UNAIDS, becomes 
universally available. The package of 
services includes (in order of priority):
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1. needle and syringe programmes 
(NSPs)
2. opioid substitution therapy (OST) and 
other evidence-based drug depend-
ence treatment
3. HIV testing and counselling (HTC)
4. antiretroviral therapy (ART)
5. prevention and treatment of sexually 
transmitted infections (STIs)
6. condom programmes for PWID and 
their sexual partners
7. targeted information, education and 
communication (IEC) for PWID and 
their sexual partners
8. prevention, vaccination, diagnosis 
and treatment for viral hepatitis
9. prevention, diagnosis and treatment 
of tuberculosis (TB)
10. community distribution of Naloxone.
The tenth intervention is from the WHO 
Consolidated Key Population Guideline 
(2016). 
State of harm reduction  
services globally 
Details:    2 mins      Slides 121–122
Globally, we are far from providing 
universal access to these services. For 
example, the 2016 report by Harm Reduc-
tion International highlights that of the 
158 countries where injecting drug use 
has been documented, less than two 
thirds are implementing some form of 
NSP and only half have at least one OST 
programme. Earlier studies (2010) by 
the World Bank and other researchers 
(Mathers et al.) showed that access to 
ART and services among women who 
inject drugs was particularly low. The state 
of services for PWID will be presented 
later by representatives from and working 
with the community of PWID. 
Overview of the IDUIT and training 
Details:  5 minutes    Slides 123–125
The IDUIT builds on other UN guidance 
documents. This guidance is grounded 
in an approach to increase accessibility, 
acceptability, coverage and quality, and 
update interventions and services, by 
focusing on critical enablers (law and 
policy reform; implementation of anti-dis-
crimination and protective laws; availa-
bility, accessibility and acceptability of 
health services; community empower-
ment; and addressing violence).
Similar toolkits have focused on sex 
workers (referred to as SWIT), men 
who have sex with men (referred to 
as MSMIT) and transgender people 
(referred to as TRANSIT) (  Slide 123). 
The development of the IDUIT started 
in 2014. Community and other experts 
contributed and it was finalised in late 
2016. It provides guidance on how to 
implement HIV and HCV programmes 
with PWID. It targets health officials, 
managers of HIV and harm reduction 
programmes, civil society organisations, 
health workers and communities of 
PWID (  Slide 124). 
It provides guidance on how to imple-
ment, and includes five chapters: 
1. Community Empowerment 
2. Legal Reform, Human Rights, Stigma 
and Discrimination 
3. Health and Support Services 
4. Service Delivery Approaches 
5. Programme Management
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Each chapter includes details, guidance, 
case studies and a comprehensive 
resource list (  Slide125).
The central role of people who use 
drugs 
Details:   1 min    Slide 126
An important focus of the IDUIT is to 
highlight the essential role that commu-
nities of PWUD play in implementing 
an effective HIV response. Community 
organisations are important in the imple-
mentation of health, social and other 
services. They provide linkages to health 
services and also should be involved 
in data collection, analysis, guidance 
and quality improvement. Meaningful 
community participation is key from 
the onset and across all parts of the 
programme.
  
Session 16: Local Policy Context 
Session:  30 minutes    Slide 127 as 
placeholder + presentations from policy 
makers
Aim: To provide an overview of relevant 
policy and policy reform around drug use, 
HIV and related conditions
Learning objective: To become aware 
of existing and planned policy relevant to 
HIV, HCV and PWID 
Expected outcome: Participants under-
stand the policy context, including recent 
and planned developments
Main point: Overview of local policy 
context
Session components: Presentations
The facilitators should introduce each 
policy maker and allow them to give their 
presentation. Request that participants 
note down any questions and keep them 
for the interactive dialogue session that 
will follow. 
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Materials needed
Projector and  
slide set
 Session 17: Overview of Local HIV 
and HCV Programming for PWID 
Session:  30 minutes    Slide 128  
presentations from organisations
Aim: To allow representatives of organi-
sations providing services to PWID, and 
who were involved in the training work-
shop, to provide an overview of ongoing 
HIV and HCV programmes to policy 
makers
Learning objectives:
• Representatives of organisations led 
by and/or working with PWID to share 
with policy makers their experiences 
and scope of programming 
• Current challenges and requests from 
policy makers to be tabled around HIV 
and HCV policy and programmes for 
PWID 
Expected outcome:
• Increased awareness among policy 
makers of the role that PWID are 
playing, and have the potential to play, 
in programme implementation 
Main point: Scope and distribution of 
HIV and HCV services for PWID
Session component:
• Presentations
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Materials Needed
Projector and  
slide set
Facilitators’ Notes
Request recent biographies of the 
participating policy makers which can 
be read as they are introduced. 
Request policy makers to cover latest 
policies and practice guidance related 
to healthcare, education and social 
services for PWID in the country. 
Request that they also note any future 
plans in their presentation.
Structure the meeting to allow time 
for interaction between policy makers 
and service providers and other partic-
ipants. Limit the length of presenta-
tions by: 
1. providing accurate information to 
policy makers in preparation
2. confirming their allocated time on 
the agenda;
3. restricting the policy overview 
session to 30 minutes 
4. using a time keeper and time cards.
The facilitators should introduce each 
representative who will present around 
HIV and HCV programmes with PWID. 
Request that participants note down any 
questions and keep them for the interac-
tive dialogue session that will follow. 
To allow sufficient time for interaction 
between policy makers, service providers 
and other participants, use a time keeper 
and time cards (as per the allocated time 
decided upon the previous day).
 
Session 18: Facilitated Dialogue 
Session:   85 mins    Slide 129
Aim: To provide an opportunity to 
discuss challenges, concerns and issues 
Learning objectives:
• To provide a platform to highlight chal-
lenges and concerns
• To engage around potential solutions 
Expected outcome: Clarification of 
priority issues, with different perspec-
tives being verbalised
The facilitator or another nominee should 
facilitate a discussion between policy 
makers and participants. A policy maker 
and presentation panel could be set up, 
initially to address questions raised during 
presentations or responses developed. 
Once these issues have been addressed, 
the question-and-answer session should 
be opened to the floor. 
The facilitator should be mindful and 
guide discussions and implement risk 
mitigation strategies to keep engage-
ment positive. 
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Facilitators’ Notes
Request recent biographies of the 
participants which can be read as they 
are introduced. 
Materials Needed
Microphone(s)
Note taker
 Session 19: The Way Forward
Session:  30 mins     Slides 130–131
Aim: To provide an opportunity to discuss 
the next steps for further engagement  
Learning objective: To identify short-, 
medium- and long-term actions
Expected outcome: A list of activities 
and plans, noting timeframes and respon-
sible people
Session component: Plenary discussion
Inclusion of this session is important. 
The facilitator should highlight that the 
training workshop and dialogue is not 
a one-shot awareness exercise, but 
should be part of an ongoing process of 
engagement. 
The facilitator should support discussions 
around the way forward at various levels:
• Policy level
• Service delivery level
• Efforts to mobilise financing of 
community-led services and 
empowerment
• Efforts to address structural barriers
• Other priority issues/actions raised 
during the day (   Slides 130–131).
  Injecting Drug User Implementation Tool Training Manual  /  Day Three  /  Session 18 and 19 67  Injecting Drug User Implementation Tool Training Manual  /  Day Three  /  Session 17 and 18 66
Facilitators’ Notes
Aim to get a range of questions from 
people from different parts of the room, 
and different genders, socioeconomic 
and geographic perspectives, etc. 
Monitor the time to allow for discussion 
around solutions and the next steps. 
Materials Needed
Microphone(s)
Note taker
Session 20: Closing and Thanks 
Details:   15 mins    Slide132
Aim: To end the meeting  
Learning objectives:
• To confirm the positive outcomes of 
the dialogue
• To encourage commitment to ongoing 
engagement
Expected outcomes:
Participants to leave with a positive 
sense of the dialogue and understanding 
of the next steps.
Session component:
• Conclusion presentation
The facilitator should:
• recap the key elements of the day and 
any commitments made
• confirm whether contact details noted 
are correct, and obtain consent for 
information to be shared to enable 
ongoing engagement
• thank participants for their 
involvement.
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Facilitators’ Notes
If possible, facilitate discussion to 
assist the identification of actionable 
steps, as well as responsible people.
Support discussions towards the 
establishment of a joint working group 
or task force to further develop engage-
ment plans.
Assist participants in taking note 
of responsible people and, where 
possible, a timeframe. Ensure that a 
note taker is designated to capture 
important discussion points. Allow for 
contact details between participants to 
be shared for future collaboration.
Materials Needed
Microphone(s)
Facilitators’ Notes
If possible, give presenters (policy 
makers, civil society representatives, 
etc.) a small gift to thank them for 
participating in the event. 
Assessment
Questions True False
1. The 2016 Political Declaration recommends that 30% of services be 
community-led by 2030.  
2. PWUD community empowerment is recommended by  
UN guidelines. 
3. UN guidelines recommend removing criminal sanctions for drug use 
and possession for personal use.  
4. Attitudes towards PWUD can be changed through engaging with 
the media and stakeholders and providing PWUD with a voice.  
5. At needle and syringe programmes, strict exchange (requiring 
people to return used needles and syringes) is not advised.  
6. Opioid substitution therapy can reduce the risk of overdose. 
7. Testing for HIV and HCV should be available outside of medical 
settings with assistance of trained outreach workers.  
8. PWUD can help their peers adhere to HIV and HCV treatment. 
9. People who use drugs are people first and have the same needs as 
non-drug users. 
10. The World Health Organization recommends that Naloxone be made 
available to PWUD so that they can use it to reverse overdose. 
11. UN guidelines recommend that PWID be employed by harm 
reduction services.  
12. PWUD can and have run their own harm reduction services. 
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Handouts
Training Evaluation Form
    Circle one (5 = excellent, 1 = poor)
A.  The facilitators  5          4          3          2         1
1. Did you find the training plan clear? 5          4          3          2         1
2. Do you feel like you achieved  5          4          3          2         1 
your own learning goals?     
3. Were the sessions engaging? 5          4          3          2         1
4. Overall rating of facilitator(s) 5          4          3          2         1
5. If you were the trainer, what would you have done differently? 
 
 
 
B. Content and environment 5          4          3          2         1
1. Do you feel the level of workshop  5          4          3          2         1 
was suitable for participants?      
2. How was the organisation of the training,  5          4          3          2         1 
structure and content?     
3. How did you find the group work and activities? 5          4          3          2         1
4. How relevant was the content for your  5          4          3          2         1 
work and activism?      
5. How was the learning environment and facilities? 5          4          3          2         1
6. How was your accommodation and food? 5          4          3          2         1
7. What improvements would you make to the training? 
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C.  How has the workshop helped you to use the IDUIT guidelines in your future work?
 
 
 
 
 
 
 
 
 
 
 
D.  What changes will you put in place when you return to work as a result of the IDUIT 
training? 
 
 
 
 
 
 
 
 
 
 
E.  Is there anything else you would like to tell us?  
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INPUD Consensus Statement 2015
The Human Rights of People who Use Drugs
Right 1:  The Right to Rights. People who use drugs 
are entitled to their human rights, which 
must be protected by the rule of law. 
Right 2:  People who use drugs have the right to 
non-discrimination. 
Right 3:  People who use drugs have the right to life 
and security of person. 
Right 4:  People who use drugs have the right not to 
be subjected to torture or to cruel, inhuman, 
or degrading treatment.
Right 5:  People who use drugs have the right to the 
highest attainable standard of health. 
Right 6:  People who use drugs have the right to 
work, to free choice of employment, to just 
and favourable conditions of work, and to 
protection against unemployment.
Right 7:  People who use drugs have the right not to 
be subjected to arbitrary arrest or detention.
Right 8:  People who use drugs have the right to 
bodily integrity.
Right 9:  People who use drugs have the right to 
found a family entitled to protection by the 
law, entitled to privacy, and entitled to be 
free from arbitrary interference.
Right 10:  People who use drugs have the right to 
assemble, associate, and form organisations.
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INPUD’s Essential Demands
In order to realise the human rights of people who use 
drugs, the following essential demands must also be real-
ised. This list is not exhaustive; however, the consultations 
that have informed INPUD’s Consensus Statement have 
demonstrated that these demands at the very least must be 
met in order to respect and promote the health, well-being, 
and rights of people who use drugs. 
Demand 1:  People who use drugs, and drug use, must 
be decriminalised. 
Demand 2:  Decriminalisation alone is not enough: 
people who use drugs must have access to 
legal justice and police protection. 
Demand 3:  Those who enforce the law, particularly the 
police and members of the criminal justice 
system, must be sensitised to the needs and 
rights of people who use drugs. 
Demand 4:  People who use drugs must not be assumed 
to be sick, deviant, or criminal. 
Demand 5:  Drug-user phobia and drug-shaming must be 
legally recognised as discrimination and hate 
speech. 
Demand 6:  Violence perpetrated against people who 
use drugs, both in civil society and at the 
hands of the authorities, the police, and 
healthcare providers, must be investigated 
and prosecuted. 
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Consensus Statement on Drug Use Under Prohibition:  
Human Rights, Health and the Law
Demand 7:  Executions and extra-judicial killings of 
people who use drugs, and for drug-related 
offences, must end.  
Demand 8:  People who use drugs must have access to 
the highest attainable standard of healthcare, 
service provision, and harm reduction.  
Demand 9:  Harm reduction services must be available 
accessibly, freely, and comprehensively, and 
must take into account people’s nuanced and 
variable realities.  
Demand 10:  Service and healthcare providers, as well 
as the police and staff in all closed settings, 
must be sensitised to the specific needs of 
people who use drugs.  
Demand 11:  Comprehensive healthcare and harm 
reduction services must be available in all 
contexts, including closed settings such as 
prisons and pre-trial detention.  
Demand 12:  People who use drugs must be involved in 
the conception, implementation, evaluation 
and monitoring of service and healthcare 
provision. Where possible, service provision 
must be peer-led.  
Demand 13:  Barriers to health must be undermined and 
dismantled: not only must people who use 
drugs be decriminalised, but drugs must be 
produced in a legal and regulated context.  
Demand 14:  People who use drugs must not be treated 
differently from their co-workers on the basis 
of their drug use. They have the same right 
to employment as all others.  
Demand 15:  People who use drugs are entitled to a 
stable, non-hostile workplace environment.  
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Demand 16:  People who use drugs must be able to 
work without threat of arbitrary termination, 
discrimination, and harassment.  
Demand 17:  People who use drugs must not be subject 
to arbitrary detention or arrest, arbitrary stop-
and-search, compulsory treatment, or forced 
labour.  
Demand 18:  People who use drugs must not have their 
bodily integrity violated through drug testing, 
or through being pressured or coerced to 
terminate their pregnancy or to be sterilised. 
Demand 19:  Drug use alone must never justify the 
invasion or disruption of privacy or of family 
and/or domestic life.  
Demand 20:  People who use drugs must be respected 
as experts on their own lives and lived 
experiences. 
Demand 21:  Participation of people who use drugs 
in debate and policy formation must be 
meaningful, not tokenistic.  
Demand 22:  The well-being and health of people who 
use drugs and their communities must be 
considered first and foremost in the formation 
of laws and policies related to drug use.  
Demand 23:  Networks of people who use drugs must be 
able to legally register and be recognised as 
formal organisations with political legitimacy. 
Demand 24:  People who use drugs must be able to 
organise and network without fear of 
discrimination, arbitrary interference, or 
violence. 
https://www.inpud.net/consensus_statement_2015.pdf
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Needle and Syringe and Smoking Equipment Programming
Access to injecting and smoking equipment is essential for prevention of HIV and HCV trans-
mission as well as overall health promotion among people who use drugs. For many, accessing 
commodities through these services can be a gateway to other health and social services. 
What to check for: 
 Services should actively attract clients. Are they easy to enrol in?
 Services should offer a range of commodities, such as a variety of needles and syringes 
of appropriate sizes, and other materials to enable safer use, preferably free of charge.
 Services should engage people who use drugs in the selection and distribution of 
commodities.
 Services should not require clients to bring in used equipment in order to receive new 
injecting equipment, and instead should teach people how to dispose of used equip-
ment safely.
 Services should enable ‘secondary exchange’, i.e. providing enough equipment that 
people can pass new equipment on to their friends.
 Services should offer a range of other education, support and care services or referral 
relating to health and social needs.
List 3 things that local services do very well.
1.  ______________________________________________________________________________
2.  ______________________________________________________________________________
3.  ______________________________________________________________________________
List 3 things that should be improved.
1.  ______________________________________________________________________________
2.  ______________________________________________________________________________
3.  ______________________________________________________________________________
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Opioid Substitution Treatment
Opioid substitution therapy (OST) programmes help promote  
the health and well-being of people dependent on opioids. 
What to check for:
 OST should be free of charge or affordable.
 OST should be offered in a welcoming, non-stigmatising and confidential environment.
 OST should be offered in a convenient location and at convenient times  
(enabling clients to work and go about their daily affairs). 
 OST services should provide adequate doses to eliminate need for additional opioids  
in order to avoid feeling ill (adjusting doses as needed when other medical treatment, 
such as some antiretroviral medicines, requires it).
 Use of illegal drugs by OST clients should be handled in a non-punitive manner.
 Patients should be able to access the service long-term and should be offered  
a voluntary option to taper doses.
 Tapering (reducing) doses should never be done without careful thought and discussion 
with service providers of additional support that may be needed.
 A range of OST medicines such as methadone, buprenorphine and diacetylmorphine 
(medical heroin) should be offered for clients to choose from.
 Once people are stable, take-home doses should be offered as well  
as documentation needed by clients who travel.
 Social integration support should be available on a voluntary basis.
 Services should work with family and friends to create a supportive environment  
for clients (while maintaining confidentiality).
 Services should address the special needs of pregnant women (including informing 
them about the risks involved with opting to stop OST treatment or illegal opioid use 
while pregnant, and consideration of the need to increase dosage with weight gain).
 Services should provide Naloxone to first responders along with training  
in its administration.
 OST programmes should offer clients means of providing feedback on how to improve 
services and how to advocate for change when necessary.
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Voluntary Testing and Counselling  
(HIV, Viral Hepatitis B and C, TB)
Since people who use drugs have heightened vulnerability 
to tuberculosis and bloodborne viruses including HIV and 
hepatitis B and C, access to testing for these conditions is 
important.  
What to check for:
 Testing for HIV, HCV or TB should be done in line with 
the WHO’s ‘5 Cs principles’:
  consent 
  confidentiality 
  counselling
  correct test results
  connection to follow-up services.
 Testing for HIV and HCV should be available outside of 
medical settings with the assistance of trained outreach 
workers. 
 When rapid tests for HIV and HCV are used, clients 
should be assisted to access confirmation testing in 
medical settings in the case of positive results.
 All testing should be free of charge.
 Repeat testing for HIV and HCV (i.e. once every six 
months) should be offered.
 Self-testing for HIV should be made possible (whereby 
people are given test kits with instructions for private 
use). 
 Staff of harm reduction services should be aware of the 
symptoms of TB and able to make referrals to testing 
and treatment services. 
 TB screening should be available for people who use 
drugs living in countries where TB prevalence is high.
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Treatment for HIV, Hepatitis B and C,  
and TB
Globally, people who inject drugs tend to have tragically low 
access to treatment for HIV, TB and hepatitis despite strong 
evidence that treatment is as effective for people who use 
drugs as it is for other populations.  
What to check for:
 Regulatory barriers excluding people who use drugs 
from access to treatment should be removed.
 Harm reduction services should help link people to 
care or offer CD4 testing and/or clinical check-ups in 
low-threshold settings (preferably with drug user-friendly 
physicians and clinics when possible).
 Adherence support, including peer support, should be 
offered for people who use drugs.
 OST should be available for people dependent on 
opioids who choose to enrol to support their treatment 
adherence. The WHO recommends that antiretroviral 
medicines be provided at OST sites.
 Specific fears and concerns of people who use drugs 
should be addressed in treatment literacy programming.
 People who use drugs with experience of treatment for 
the relevant diseases should be engaged to provide peer 
support for treatment adherence and navigating access 
to medical and social services.
 People who drop out of treatment should be given 
special attention to address their reasons for dropping 
out.
 Measures should be in place to ensure continuity of 
treatment for people coming into and out of prison.
 Services for HIV, hepatitis, TB and OST should be 
adequately integrated to ensure convenience for 
patients.
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Sexual and Reproductive Health and Rights
Addressing the sexual and reproductive health and rights 
(SRHR) needs of people who inject drugs requires distinct 
skills and effort both within harm reduction services and in clin-
ical settings. Harm reduction services should offer commodi-
ties (condoms, lubricants) and basic education about STIs and 
reproductive health, and should also support access to clinical 
services in low-threshold settings. Women who inject drugs 
often face great stigma in clinical settings, which can dissuade 
them from accessing the care that they need. Clinical staff 
should be given sensitisation training to reduce stigma and 
improve knowledge of the special needs of people who use 
drugs. Harm reduction services can refer clients to clinics they 
know to be drug user-friendly. Sometimes, however, referral 
is not enough – people may need the costs of transportation 
to clinical services to be covered or childcare to be provided in 
order for them to access services.
What to check for:
 Condoms and lubricants and other safer sex supplies 
should be offered free of charge.
 Education about sexual and reproductive health should 
be offered as well as means of birth control. 
 Harm reduction services should address the specific 
needs and preferences of women, men who have sex 
with men, transgender people and sex workers. 
 Clinics that diagnose and treat STIs, provide family 
planning counselling and services, and provide prenatal 
care should be knowledgeable about and take into 
consideration the special needs of people who use 
drugs. Harm reduction services should refer their clients 
to clinics that they know to be ‘friendly’ to people who 
use drugs. 
 
  Handouts  /  Sexual and Reproductive Health and Rights 80
Addressing the Needs of Women
Many harm reduction programmes are 
male-dominated and may neglect the specif-
ic needs of women. Additionally, the stigma 
faced by women who inject drugs is often 
even greater than that faced by men who 
inject drugs, and this can inhibit their ability 
to access services.
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What to check for:
 Harm reduction services should make 
safe spaces available to women.
 Harm reduction services should employ 
women who use drugs and support 
community mobilisation of women who 
use drugs.
 Harm reduction services should make 
childcare services available. 
 Harm reduction services should offer 
separate spaces or opening times for 
women.
 Harm reduction services should ensure 
that sexual and reproductive health and 
rights services are accessible. 
 Harm reduction services should provide 
legal support for mothers facing 
problems with custody of their children. 
 Sexual and reproductive health services 
should provide non-judgemental 
education about the effects of drugs 
on menstruation, pregnancy and 
breastfeeding. They should address the 
dangers of opioid withdrawal during 
pregnancy. 
 Prenatal and post-natal services should 
be provided in services friendly to PWID. 
 Women who use opioids should be 
supported to access opioid substitution 
therapy.
 The myth that drug use equals child 
abuse should be opposed.
 Possession of condoms should never 
be used by law enforcement as 
evidence of engagement in sex work.
 Sterilisation or abortion should never be 
coerced or forced.
 Harm reduction services should provide 
support, counselling and referral for 
victims of gender-based violence.  
 Survivors of sexual assault should be 
linked to community-based responses 
to violence.
 
Psychological and Social Support
Factors including violence, discrimination, poverty, having a 
criminal record, experience of trauma, internalised stigma 
and others leave some people who use drugs with distinct 
psychosocial support needs. Harm reduction services should 
offer guidance and support for access to these services by 
their clients. Mobilisation of people within the community of 
people who use drugs can promote mutual support.  
What to check for:
 Harm reduction services should not assume that 
psychosocial support is needed by each client.
 Harm reduction services should help people to access 
available social services.  
 Access to these services should be voluntary.
 Social services should serve people who use drugs 
without stigma.
 Mutual support within the community of people who 
use drugs should be supported.
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Overdose
Overdose is the leading cause of drug-related deaths and 
is preventable. Overdose prevention and management pro-
grammes include the distribution of Naloxone to people who 
inject/use opioids, and to people who live and work with 
them, to save lives and empower communities. 
What to check for:
 Harm reduction programmes should offer training on 
overdose, including resuscitation and administration of 
Naloxone, to people who use opioids and their friends 
and families. 
 Detoxification/rehabilitation programmes, post-release 
programmes for prisoners, and providers of services to 
people who use drugs should offer training on overdose 
and distribute Naloxone to people who use drugs and 
their friends and families.
 Legal or regulatory barriers to providing or administering 
Naloxone outside of medical facilities should be removed.
 Trainings and educational materials should cover how to 
recognise an opioid overdose and how to perform resus-
citation on someone overdosing on drugs that Naloxone 
will not help with.
 Local myths about overdose should be addressed in 
trainings and educational materials.
 Naloxone should be available in pharmacies.
 First responders (fire, ambulance, police) should be 
equipped with Naloxone.
 Law enforcement should be prevented from accompa-
nying emergency services responding to overdose.
 Means to check the quality and purity of drugs should be 
available to people who use drugs. For example, strips 
designed to identify fentanyl in urine may help people 
identify fentanyl in drugs. Though the evidence base 
for using fentanyl strips this way is limited, it should be 
explored urgently.  
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Drug Purity-Checking Programmes
Prohibition leads to unregulated production of drugs, which 
can lead to inconsistent quality and purity. This can lead to 
major health harms including death. Programmes enabling 
people who use drugs to test their drugs can help them to 
make safer informed choices about what they consume. 
Though not addressed in the IDUIT, some key considerations 
are reiterated here.
What to check for:
 There should be ongoing action to advocate legalisation 
of drugs. (As one informant quoted in User-Activists’ 
Views highlighted: ‘If drugs were legal, we wouldn’t 
need to test them … all the information you’d need … 
it’d be right there on the label.’)
 Drug-checking kits on a full spectrum of drugs, including 
opioids, should be available through harm reduction 
services or special sites.
 Festival operators and club owners should provide drug-
checking services.
 There should be mechanisms in place to respond to 
outbreaks of tainted/adulterated drugs.
 Harm reduction staff should be able to handle drugs for 
checking without fear of legal prosecution.
 Further research on drug-checking programmes should 
be promoted.
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Sample Community Committee Report
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The International Network of People who Use Drugs 
(INPUD) is a global peer-based organisation that 
seeks to promote the health and defend the rights 
of people who use drugs. INPUD will expose and 
challenge stigma, discrimination, and the criminalisa-
tion of people who use drugs, and its impact on the 
drug-using community’s health and rights. INPUD will 
achieve this through processes of empowerment and 
advocacy at the international level, while supporting 
empowerment and advocacy at community, national 
and regional levels. www.inpud.net
INPUD is part of Bridging the Gaps – health and rights 
for key populations. This unique programme addresses 
the common challenges faced by sex workers, people 
who use drugs and lesbian, gay, bisexual and trans-
gender people in terms of human rights violations and 
accessing much-needed HIV and health services. Go 
to www.hivgaps.org for more information.
INPUD is very grateful for financial support from 
Bridging the Gaps and the Robert Carr civil society 
Networks Fund. 
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